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Although enormous efforts have been made to eradicate 
leishmaniasis through vaccination but complete protection has 
never been achieved. Therefore in the present study we have 
made a vaccination trial against leishmaniasis in golden 
hamsters. Three different leishmania antigenic fractions 
constituting whole, particulate and soluble (alone and in 
association with BCG) antigens were used for immunization 
experiments. 
In vitro cultivation of Leishmania donovani (NICD: C II 
strain) was carried out in Brain Heart Infusion Agar medium. 
Promastigotes obtained from 6 day cultures were washed 6 
times in HBSS by centrifugation at a speed of 2000-2500 rpm 
for 30 min. A clear homogenate was prepared in a homogenizer 
for obtaining the whole antigen. The whole antigen was 
centrifuged at 105, 000 x g for 1 h, in an ultracentrifuge at 
4°C to get particulate and soluble antigen fractions. 
Leishmania antigen, before being used for immunization 
were characterized by estimating protein, carbohydrate and 
DNA contents. The SDS-PAGE was carried out for molecular 
weight determination and separation of protein sub-units of 
each fraction. The antigenicity of these antigenic fractions 
was checked against antisera obtained from cases of kala-
azar. IFA, IHA and ELISA tests were employed to detect the 
antigenic activity of whole, particulate and soluble 
antigenic fractions. 
Immunization experiments were carried out in golden 
hamsters of 80-100 gms. In the first experiment, the animals 
were intraperitonal ly injected with whole, particulate and 
soluble antigenic fractions. In the second set of 
experiments, the animals were intraperitonally injected with 
different antigenic fractions in association wth BCG (Bacille 
Calmette-Guerin) as an immunomodulator. Control animals 
received either BCG or saline only. Every hamster was 
i ntraperitonal 1 y injected four times with 0.2 mg antigen 
protein with or without BCG (2 x 10 Bacille Calmette-guerin) 
at four day intervals. 
The antibody titres were detected by IHA and ELISA at 
day 30, 45 and 60 following last immunizing dose. Animals 
immunized with antigen plus BCG showed titre values greater 
than those which received antigen only. In IHA and ELISA 
tests, the highest antibody titres were found in animals 
immunized with soluble antigen in association with BCG 
following particulate and whole antigen in association with 
BCG. The immunoglobulin (IgG and IgM) levels were also 
detected by single radial immunodiffusion technique in 
hyperimmune sera on day 45 following last immunizing dose. 
The animals immunized with antigen in association with BCG 
XI 
showed higher immunoglobulin levels compared to animals 
immunized with antigen only. Moreover, highest 
immunoglobulin levels were found in animals immunized with 
soluble antigen in association with BCG following 
particulate and whole antigen in association with BCG. The 
appearance of cell mediated immunity in these animals was 
demonstrated by delayed type hypersensitivity (DTH) response. 
The DTH was measured by foot pad swelling response to phenol 
suspension of promastigotes. This test was negative in all 
hamsters immunized with leishmania antigens (with or without 
BCG), when tested at day 30, 45 and 60 following the last 
immunizing dose. Hamsters which received parasite antigen 
plus BCG showed leukocytosis, while hamsters which received 
parasite antigen only showed almost normal leukocyte counts 
compared to control hamsters. The percentage of 
polymorphonuclear cells was higher in the antigen plus BCG 
group than in the antigen group only. 
Experimental and control hamsters were challenged by 
intraperitoneal injection of vialble i.. donovan i 
promastigotes on day 45 following last immunizing dose. Each 
hamster received a challenge dose containing 1 ml of 1x10'^  
promastigotes from log phase. The antibody titres were 
assessed by employing IHA and ELISA on day 30, 45 and 60 post 
challenge. Hamsters which received antigen in association 
with BCG showed higher antibody titres than those given 
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antigen only. The highest antibody titres were recorded in 
animals immunized with soluble antigen in association with 
BCG following particulate and whole antigen in association 
with BCG. Also, highest immunoglobulin levels were found in 
animals immunized with soluble antigen in association with 
BCG following particulate and whole antigen in association 
with BCG. The DTH was positive only in animals which received 
parasite antigen in association with BCG. The highest 
percentage of foot pad swelling was recorded in hamsters 
immunized with soluble antigen in association with BCG. 
Parasitaemia and foot pad lesions were developed only in 
control animals. In vitro cell mediated immune response by 
macrophage migration inhibition test was also assessed. 
Highest percentage of migration inhibition values were 
obtained from hamsters which received soluble antigen in 
association with BCG following particulate and whole antigen 
ijX- association with BCG. The hamsters of antigen-BCG group 
showed higher TLC with slight increase in lymphocyte and 
monocyte counts. The control animals and those which received 
parasite antigen only showed leukopenia accompanied with 
lymphocytosis and slight increase in monocytes. 
All animals immunized with leishmania antigen in 
association with BCG showed significant reduction in hepatic 
and splenic parasite counts on day 15, 30, 45 and 60 post 
challenge compared to animals immunized with leishmania 
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a n t i g e n o n l y . Animals immunized w i t h s o l u b l e a n t i g e n i n 
a s s o c i a t i o n w i t h BCG showed h i g h e s t p a r a s i t e r e d u c t i o n 
f o l l o w e d by p a r t i c u l a t e and who le a n t i g e n i n a s s o c i a t i o n 
w i t h BCG. Our h i s t o p a t h o l o g i c a l s t u d i e s showed a l m o s t no 
change i n animals immunized w i t h an t igen in a s s o c i a t i o n w i t h 
BCG. However, moderate number of LD bodies were observed in 
hyperplased macrophages o f animals immunized w i t h an t i gen 
on! y. 
Since complete p r o t e c t i o n of immunized animals was not 
o b t a i n e d i n t h i s s tudy t h e r e f o r e a s m a l l dose o f d rug 
(S t ibog lucona te ) was used in order t o get one hundred per 
cent p r o t e c t i o n . A l l hamsters were i n t r a m u s c u l a r l y i n j e c t e d 
w i t h 2.5 mg/kg body weight of s t i b o g l u c o n a t e . The p r o t e c i o n 
i n d r u g t r e a t e d a n i m a l s was seen t h r o u g h o r g a n smear 
impress ions, where no p a r a s i t e was seen in these s l i d e s . Our 
s t u d i e s c l e a r l y showed t h a t s u f f i c i e n t p r o t e c t i o n can be 
e l i c i t e d i n golden hamsters aga ins t L. donovani i n f e c t i o n by 
immunizing the animals w i t h so lub le an t igen in a s s o c i a t i o n 
w i t h BCG. And , c o m p l e t e p r o t e c t i o n can be a c h i e v e d by 
i n f e c t i n g a very smal l dose o f d rug t o t h e v a c c i n a t e d 
an imals . 
1 ^ 
> TTH 
*.!.?".f*^, : , ^ i ts- ^•3^.^. :• 
T4244 
" ^ 
2 ^ 
WH \3SA 
¥13 
f'^. 
^ ( Qr^ 
^ ^ 7 o . 
VACCINATION STUDIES AGAINST 
EXPERIMENTAL. LEISHMANIASIS : 
USE OF BCG AS AN IMMUNOMODULATO R 
/j,f'-
Thesis submitted for the Degree of 
Bottor of $I|ilQ£Dpli2> 
. U IN ^U 
\" MICROBIOLOGY 
BY 
MASUDUL HASAN ANSARI 
V. ? 
I PARASITIC IMMUNOLOGY LABORATORY 
DEPARTMENT OF MICROBIOLOGY 
JAWAHARLAL NEHRU MEDICAL COLLEGE 
ALIGARH MUSLIM UNIVERSITY 
ALIGARH (INDIA) 
1993 
CERTIFICATE 
This s^ to certify that the research incorporated in the thesis 
entitled "Vaccination Studies Against Experimental Leishmaniasis: Use 
of BCG as an Immunomodulator" has been carried out in my laboratory by 
Mr. Masudul Hasan Ansari. I consider this work suitable for submission 
for the award of Ph. D. Degree in Microbiology of the Faculty of Medicine, 
J. N. Medical College, Aligarh Muslim University, Aligarh. 
vliylviAM/ AHkvvvtv/i/ 
(SOhlAIL AHMAD) 
Ph. D. 
Professor 
Department of Microbiology 
J. N. Medical College 
Aligarh Muslim University 
November 15, 1993 Aligarh-202 002 (INDIA) 
A-^^garh , ^1 
CONTENTS 
Page No. 
Contents I 
LIST OF FIGURES III 
LIST OF TABLES V 
Acknowledgements VII 
SUMMARY IX 
INTRODUCTION 
1. Historical Review 1 
2. Taxonomy 3 
3. Life Cycle 6 
4. In vitro Cultivation 8 
12 
18 
23 
30 
34 
38 
42 
45 
49 
49 
51 
3. Antigen Purification 52 
4. Characterization of Antigen 52 
5. Immunization Studies 66 
6. Protect"ion Studies 71 
7. Drug Treatment 75 
RESULTS 
1. Axenic in vitro Cultivation of L_. 
donovani (NICD: II strain) 77 
5. 
6. 
7. 
8. 
9. 
10, 
AIMS AND 
Parasite Antigen 
Vaccination Studies 
Immune Responses 
Macrophage-Parasite 
Pathology 
.Drug Therapy 
OBJECTIVES 
MATERIALS 
METHODS 
1. 
2. 
In vitro cultivation 
In vitro Maintenance 
Relationship 
of 
of 
Parasite 
Parasite 
II 
2. Purification and partia-1 characteri-
zation of parasite antigen. 77 
3. Immunization Studies 85 
4. Protection Studies 94 
5. Organ Impression Smears. 107 
6. Assay of Acid Phosphatase 107 
7. Histopathological Studies 107 
8. Drug Treatment 115 
DISCUSSION 122 
CONCLUSION 145 
BIBLIOGRAPHY 148 
Ill 
LIST OF FIGURES 
Fig.1 Photograph showing Leishman stained L. 78 
donovani (NICD:C II strain) promastigotes 
from a 6 day old culture 
Fig.2 Growth Curve of L. donovani (NICD:C II 79 
strain) 
Fig.3 ELISA titres of different antigenic 84 
fractions. 
Fig.4 SDS PAGE profile of L. donovani (NICD:C 86 
II strain) promastigate antigens. Marker 
proteins have also been shown. 
Fig.5 Typical calibration curve of SDS PAGE 87 
(7-15* SDS gel ) . 
Fig.6 Histogram showing Immunoglobulin (IgG 93 
and IgM) levels on day 45 post 
•immunization and post challenge. 
Fig. 7 Photograph of spleen and liver from a 99 
normal hamster showing no splenomegaly 
and hepatomegaly. 
Fig.8 Photograph of spleen and liver from a 100 
control hamster following challenge 
showing splenomegaly and hepatomegaly. 
Fig.9 Histogram showing splenic parasite count 108 
in immunized hamsters after challenge. 
Fig.10 Histogram showing concentration of acid 114 
phosphatases in macrophages after 
challenge. 
Fig.11 Liver section from a control hamster 116 
after challenge showing numerous L.D. 
bodies in parasitized macrophages. The 
arrow indicate L.D. bodies (H&E x 1000). 
Fig.12 Spleen section from a control hamster lie 
after challenge showing accumulation of 
parasitized macrophages. The arrows 
indicate the L.D. bodies (H&E x 1000). 
Fig.13 Liver section from an animal immunized 117 
with whole antigen + BCG showing 
hyperplasia of Kupffer cells (H&E x 400) 
IV 
F i g . 1 4 Sp leen s e c t i o n f r o m an an ima l immunized 117 
w i t h w h o l e a n t i g e n + BCG s h o w i n g 
p a r a s i t i z e d macrophages (H&E x 4 0 0 ) . 
F i g . 1 5 L i v e r s e c t i o n f r o m an an ima l immunized 118 
w i t h p a r t i c u l a t e a n t i g e n + BCG showing 
h y p e r p l a s i a o f K u p f f e r c e l l s (H&E x 400) 
F i g . 1 6 Spleen s e c t i o n f r om an an ima l immunized 118 
w i t h p a r t i c u l a t e a n t i g e n + BCG showing 
w h i t e p u l p i n v a d e d w i t h m o d e r a t e 
p a r a s i t i z e d macrophages (H&E x 4 0 0 ) . 
F i g . 1 7 L i v e r s e c t i o n f r o m an an ima l immunized 119 
w i t h s o l u b l e a n t i g e n + BCG s h o w i n g 
a c c u m u l a t i o n o f m a c r o p h a g e s w i t h no 
p a r a s i t e (H&E x 4 0 0 ) . 
F i g . 1 8 Spleen s e c t i o n f r o m an an ima l immunized 119 
w i t h s o l u b l e a n t i g e n + BCG s h o w i n g 
w h i t e p u l p i n v a d e d w i t h a l m o s t no 
p a r a s i t i z e d macrophages (H&E x 4 0 0 ) . 
F i g . 1 9 Photograph showing compar i son o f s p l l e e n 121 
and l i v e r f r o m a n o r m a l and p r o t e c t e d 
a n i m a l s h o w i n g no s p l e n o m e g a l y a n d 
hepa tomega ly . 
LIST OF TABLES 
Table 1 Immunization Schedule 65 
Table 2 Immunization Schedule 67 
Table 3 Rate of Multiplication of L. donovani 80 
(NICDD:C II Strain) 
Table 4 Biochemical characteriation of L. 82 
donovani antigen fractions (NICD:C II 
strai n) 
Table 5 IHA Test against Positive Kala-azar 83 
patient sera 
Table 6 IHA titres following immunization in 89 
Days (Mean + SD range) 
Table 7 IHA titres following immunization in 90 
Days (Mean ± SD range) 
Table 8 ELISA titres in Hamsters following 91 
immunication in Days (Mean + SD range) 
Table 9 ELISA titres in Hamsters following 92 
immunization in Days (Mean ± SD range) 
Table 10 Total Leuckocyte Count in Hamsters 95 
following Immunization Mean TLC/mm + SD 
Table 11 Total Leuckocyte Count in Hamsters 96 
following Immunization Mean TLC/mm + SD 
Table 12 Hematological changes following Immuni- 97 
zation + Hamsters (Days) Mean DLC 
Percent 
Table 13 Haematological Changes on day 30 and 60 98 
Post Immunization (Mean DLC Percent) 
Table 14 IHA titres following challenge in Days 102 
(Mean ± SD range) 
Table 15 IHA titres following challenge in Days 103 
(Mean + SD range) 
Table 16 ELISA titres in Hamsters following 104 
challenge in Days (Mean + SD range) 
Table 17 ELISA titres following challenge in 105 
Days (Mean ± SD range) 
VI 
Table 18 DTH response to L. donovani Mean % 106 
increase ± SE (range at days, post 
i nfection) 
Table 19 Macrophage Migration Inhibition 109 
Table 20 Hepatic Parasite Count in Immunized 110 
Hamsters on day 15, 30, 45 and 60 Post 
Challenge Mean (=SD x 10) 
Table 21 Hepatic Parasitic Count in Immunized 111 
Hamsters on day 15 30, 45 and 60 Post 
Challanege Mean (=SD x 10) 
Table 22 Splenic Parasite Count in Immunized 112 
Hamsters on day 15, 30, 45 and 60 Post 
Challenge Mean (=SD x 10) 
Table 23 Splenic Parasite Count in Immunized 113 
Hamsters on day 15, 30, 45 and 60 Post 
Challenge Mean (=SD x 10) 
VII 
ACKNOVJLEDGEMENT 
I donot find words enough to express my gratitude for Prof. 
Sohail Ahmad, Chairman, Department of Microbiology, who has been 
a source of inspiration and encouragement to me throughout the course 
of this study. I am immensely grateful and indebted to him for his 
excellent guidance, valuable suggestions, fruitful discussion. His 
magnanimous and indepth knowledge of the subject always came in handy 
for my rescue at every difficult step of this work. 
I have been most lucky to meet Prof. Wajih A. Nizami, Depart-
ment of Zoology, who has given a new turne in my life and has been 
a sole source of inspiration like a light house. He is not only a 
best guide but also an ideal and noble man with countless commendable 
qualities. I can never forget the care, love and encouragement given 
to me during the critical stages of research. 
I wish to express my sincere regards to Dr. Haris Manzoor 
Khan, Lecturer, DeDartment of Microbiology, and Dr. Mashiatullah 
Siddique, Lecturer, Department of Biochemistry, for infusing ispirat-
ion at every stage of this work. He always willingly spared much 
of his precious time to discuss my problems. 
I am especially indebted to my loving sister. Miss Huma Umar 
for her continued and unfailing help and inspiration at every stage 
of this work. She always cheerfully assisted me whenever I needed 
her help. 
I am very much grateful to my best colleagues, Miss Sabiha, 
who has not only helped me during the practical works but also till 
the binding and submission of thesis. 
I wish to record my thanks to my colleagues who have generously 
nelped me during the course of this study. Thanks are due to Dr. 
Abbas All Mahdi, Dr. Fakhrul Islam, Dr. 5. M. Abbas Abidi, Dr. Naseem 
Knan, Or, Yagana Bano, Dr. Raka Khanna, Mr. S. M. Z. Naqvi, Mr. Afsar 
VIII 
Ali Khan, Mr. Irshadullah, Mr. Khalid Saifullah, Mr. Gul Ahmad, Miss 
Neeru Sharma, Miss Naz Bano Khan, Miss Farah Mirza and Miss Azra 
Abid for their kind help. 
I am particularly thankful to my very loving younger brothers, 
Mr. Noorullah, Mr. Mohammad Nadeem and Mr. Azhar Sajjad for their 
continued help. 
I am highly obliged to two of my friends Mr. Ghazanfar Ali 
Khan and Mr. Khalid Nasir Siddique for their continued help at every 
stage of this work. They have also helped me in Leishmania culture. 
I wish to gratefully acknowledge the help and assistance of 
Mr. Shamim Ahmad, Mr. Wasi Husain and Mr. Imtiaz Ahmad. 
I sincerely acknowledge, with thanks for the patience and 
Dua of my family members without which this thesis could never have 
been the light of the day. 
I wish to express my thanks to my laboratory attendants Mr. 
Shakeel Ahmad, Mr. Munna Lai and Mr. Brij Mohan. 
Financial assistance from University Grant Commission (UGC) 
is gratefully acknowledge. 
<r~?^. /: ^^72^ 
Masudul Hasan Ansari 
S U M M A R V 
IX 
Although enormous efforts have been made to eradicate 
leishmaniasis through vaccination but complete protection has 
never been achieved. Therefore in the present study we have 
made a vaccination trial against leishmaniasis in golden 
hamsters. Three different leishmania antigenic fractions 
constituting whole, particulate and soluble (alone and in 
association with BCG) antigens were used for immunization 
experiments. 
In vitro cultivation of Leishmania donovani (NICD: C II 
strain) was carried out in Brain Heart Infusion Agar medium. 
Promastigotes obtained from 6 day cultures were washed 6 
times in HBSS by centri f ugation at a speed of 2000-2600 rpm 
for 30 min. A clear homogenate was prepared in a homogenizer 
for obtaining the whole antigen. The whole antigen was 
centrifuged at 105, 000 x g for 1 h, in an ultracentrifuge at 
4°C to get particulate and soluble antigen fractions. 
Leishmania antigen, before being used for immunization 
were characterized by estimating protein, carbohydrate and 
DNA contents. The SDS-PAGE was carried out for molecular 
weight determination and separation of protein sub-units of 
each fraction. The antigenicity of these antigenic fractions 
was checked against antisera obtained from cases of kala-
azar. IFA, IHA and ELISA tests were employed to detect the 
a n t i g e n i c a c t i v i t y o f w h o l e , p a r t i c u l a t e and s o l u b l e 
a n t i g e n i c f r a c t i o n s . 
Immun iza t ion exper imen ts were c a r r i e d o u t i n g o l d e n 
hamsters o f 80-100 gms. In the f i r s t exper iment , the animals 
were i n t r a p e r i t o n a l ly i n j e c t e d w i t h whole, p a r t i c u l a t e and 
s o l u b l e a n t i g e n i c f r a c t i o n s . I n t h e second s e t o f 
exper iments , the animals were i n t r a p e r i t o n a l l y i n j e c t e d w i t h 
d i f f e r e n t an t i gen i c f r a c t i o n s i n a s s o c i a t i o n wth BCQ ( B a c i l l e 
Ca lmet te -Guer •* n ) as an immunomodu 1 a t o r . C o n t r o l a n i m a l s 
r e c e i v e d e i t h e r BCG o r s a l i n e o n l y . Eve ry h a m s t e r was 
i n t r a p e r i t o n a l 1 y i n j e c t e d f o u r t i m e s w i t h 0 .2 mg a n t i g e n 
p r o t e i n w i t h or w i thou t BCG (2 x 10 B a c i l l e Ca lme t te -guer in ) 
a t fou r day i n t e r v a l s . 
The ant ibody t i t r e s were detec ted by IHA and ELISA- a t 
day 30, 45 and 60 f o l l o w i n g l a s t immunizing dose. Animals 
immunized w i t h ant igen p lus BCG showed t i t r e values g rea te r 
than those which rece i ved a n t i g e n o n l y . I n IHA and ELISA 
t e s t s , t he h i g h e s t an t i body t i t r e s were f ound i n a n i m a l s 
immunized w i t h s o l u b l e a n t i g e n i n a s s o c i a t i o n w i t h BCG 
f o l l o w i n g p a r t i c u l a t e and whole an t igen in a s s o c i a t i o n w i t h 
BCG. The immunoglobul in ( IgG and IgM) l e v e l s were a l s o 
d e t e c t e d by s i n g l e r a d i a l i m m u n o d i f f u s i o n t e c h n i q u e i n 
hyperimmune sera on day 45 f o l l o w i n g l a s t immunizing dose. 
The animals immunized w i t h an t igen in assoc i a t i on w i t h BCG 
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showed h ighe r immunog lobu l in l e v e l s compared t o a n i m a l s 
i m m u n i z e d w i t h a n t i g e n o n l y . M o r e o v e r , h i g h e s t 
immunoglobul in l eve l s were found in animals immunized w i t h 
s o l u b l e a n t i g e n i n a s s o c i a t i o n w i t h BCG f o l l o w i n g 
p a r t i c u l a t e and whole an t igen in a s s o c i a t i o n w i t h BCG. The 
appearance of c e l l mediated immun i t y i n t h e s e a n i m a l s was 
demonstrated oy delayed type h y p e r s e n s i t i v i t y (DTH) response. 
The DTH was measured by f o o t pad s w e l l i n g response t o phenol 
suspension of p romast igo tes . This t e s t was negat ive in a l l 
hamsters immunized w i th le ishmania ant igens ( w i t h or w i t h o u t 
BCG), when tes ted at day 30, 45 and 60 f o l l o w i n g the l a s t 
immunizing dose. Hamsters which rece ived p a r a s i t e an t igen 
p lus BCG showed l eukocy tos i s , wh i l e hamsters which rece ived 
p a r a s i t e ant igen only showed almost normal leukocyte counts 
compared t o c o n t r o l h a m s t e r s . The p e r c e n t a g e o f 
polymorphonuclear c e l l s was h igher in the an t igen p lus BCG 
group than in the ant igen group o n l y . 
Experimental and c o n t r o l hamsters were cha l lenged by 
i n t r a p e r i t o n e a l i n j e c t i o n o f v i a l b l e L- donovan i 
promast igotes on day 45 f o l l o w i n g l a s t immunizing dose. Each 
hamster received a cha l lenge dose con ta i n i ng 1 ml of 1x10 
p r o m a s t i g o t e s f rom log phase. The a n t i b o d y t i t r e s were 
assessed by employing IHA and ELISA on day 30, 45 and 60 post 
cha l l enge . Hamsters which rece ived an t igen in a s s o c i a t i o n 
w i t h BCG showed h igher a n t i b o d y t i t r e s t h a n t h o s e g i v e n 
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antigen only. The highest antibody titres were recorded in 
animals immunized with soluble antigen in association with 
BCG following particulate and whole antigen in association 
with BCG. Also, highest immunoglobulin levels were fouhd in 
animals immunized with soluble antigen in association with 
BCG following particulate and whole antigen in association 
with BCG. The DTH was positive only in animals which received 
parasite antigen in association with BCG. The highest 
percentage of foot pad swelling was recorded in hamsters 
immunized with soluble antigen in association with BCG. 
Parasitaemia and foot pad lesions were developed only in 
control animals. XD vi tro cell mediated immune response by 
macrophage migration inhibition test was also assessed. 
Highest percentage of migration inhibition values were 
obtained from hamsters which received soluble antigen in 
association with BCG following particulate and whole antigen 
in association with BCG. The hamsters of antigen-BCG group 
showed higher TLC with slight increase in lymphocyte and 
monocyte counts. The control animals and those which received 
parasite antigen only showed leukopenia accompanied with 
lymphocytosis and slight increase in monocytes. 
All animals immunized with leishmania antigen in 
association with BCG showed significant reduction in hepatic 
and splenic parasite counts on day 15, 30, 45 and 60 post 
challenge compared to animals immunized with leishmania 
XIII 
antigen only. Animals immunized with soluble antigen in 
association with BCG showed highest parasite reduction 
followed by particulate and whole antigen in association 
with BCG, Our histopathol ogica1 studies showed almost no 
change in animals immunized with antigen in association with 
BCG. However, moderate number of LD bodies were observed in 
hyperplased macrophages of animals immunized with antigen 
onl y. 
Since complete protection of immunized animals was not 
obtained in this study therefore a small dose of drug 
(Stibogluconate) was used in order to get one hundred per 
cent protection. All hamsters were intramuscularly injected 
with 2.5 mg/kg body weight of stibogluconate. The protecion 
in drug treated animals was seen through organ smear 
impressions, where no parasite was seen in these slides. Our 
studies clearly showed that sufficient protection can be 
elicited in golden hamsters against I. donovani infection by 
immunizing the animals with soluble antigen in association 
with BCG. And, complete protection can be achieved by 
infecting a very small dose of drug to the vaccinated 
animals. 
INTRODUCXION 
1. Historical Review 
Leishmanias are flagellated protozoan parasites, they 
are the causative agents of a variety of human diseases 
termed leishmaniasis. The leishmaniasis today appears to be a 
far more prevalent disease having a much greater public 
health importance than what was previously thought, Rough 
estimates based on extrapolations of the scarce data 
available indicate that some 350 million people in the world 
are at risk of acquiring leishmaniasis and that approximately 
12 million people per year are currently infected (Report of 
WHO Expert Committee, 1990, Olliaro and Bryceson, 1993). 
Visceral leishmaniasis is caused by Leishmania donovani 
and spread by the bite of infected sand flies. The 
etiological agent, L. donovani is named after the discoverer, 
Leishman and Donovan, both of whom reported on the organism 
simultaneously; Leishman first published his report from 
London (UK) in May 1903, while Donovan reported from Madras 
(India ) in July 1903 (Chatterjee, 1982). 
The parasite Leishmania was first seen in 1885 by 
Cunningham while examining a histlogical section from an 
oriental sore in India. This organism at that time was 
thought to be a Mycobacterim and subseuently, in 1989 
Brovosky established the protozoan nature of the parasite. As 
mentioned earlier, it was Leishman (1903) who for the first 
time described this organism as a causative agent of visceral 
leishmaniasis in man. Rogers (1904) and Nicolle (1908a) 
established the trypanosomatid nature of L. donovani and L. 
tropica. Also, Nicolle (1908b) mentioned about the causative 
agent of infantile kala-azar and named them as L. infantum. 
It is more commonly found in the mediterranean countries, as 
also in other parts of Asia, Europe and Africa. In 1951 
Yokimoff and Scholhov described L. tropica major as the 
causative agent of zoonotic cutaneous leishmaniasis. It was 
Bray in 1977 who established the name L. aethiopica for the 
causative agent of cutaneous as well as more diffused 
cutaneous leishmaniasis in Europe and Kenya. Muniz and Medina 
in 1946 described and discovered L. enrietti i in guinea pigs 
in Panama State and Brazil. Biagi 1953 and Floch in 1954 
referred to L. tropica mexicana as the causative agent of 
"Chiclero's ulcer", the name that stems from the time that 
leishmaniasis was an occupational disease of gum (chile) 
collectors. It is currently associated with farming and a 
variety of forestry activities. L. tropica guyanensis and L. 
tropica brazil iensis are responsible for causing cutaneous 
leishmaniasis and mucocutaneous leishmaniasis, respectively 
(Zuckerman and Lainson, 1977). 
However, mucocutaneous leishmaniasis is a name 
currently applied only to New World disease known as 
"espundia", which is caused by L. braziliensis and L. 
panamensis (both species of the subgenus Viannia) (Santrich 
e t a1 , 1990 ) . So f a r , e f f o r t s have been made t o i d e n t i f y 
L e i s h m a n i a o n l y a t t h e s p e c i e s and s u b s p e c i e s l e v e l s , as 
o r i g i n a l l y d e f l n w d by L a 1 n » o n e n d B r i t y ( 1 « 7 8 , 1 9 B 7 ) < T h « 
m e t h o d s ana t o o l s d e v e l o p e d f o r t h e p u r p o s e i n c l u d e : 
i soenzyme p r o f i l i n g (Le B l a n q e t a l , 1 9 8 7 ) , m o n o c l o n a l 
a n t i b o d i e s ( G r i m a l d i e t a l , 1987 ) , chromosomal s e p a r a t i o n 
( G a i n n i a n i e t a l , 1986; S p i t h i l l and Samaras, 1 9 8 5 ) , k-DNA 
and genomic DNA r e s t r i c t i o n a n a l y s e s ( L o p e s e t a l , 1 9 8 4 ; 
B a r k e r e t a l , 1986; B a r k e r , 1 9 8 7 ; B e v e r l e y e t a l , 1 9 8 7 ; 
R a m i r e z and G u e v a r a , 1 9 8 7 ) . More r e c e n t l y , U l i a n a e t a l 
(1991) have d e s c r i b e d a m o l e c u l a r p robe t h a t r e c o g n i z e d t h e 
g e n u s L e i s h m a n i a , r e g a r d l e s s o f t h e s u b g e n e r i c t a x a . 
F u r t h e r m o r e , t h i s probe c l e a r l y d i s t i n g u i s h e s Le i shman ia f r o m 
T r y p a n o s o m a , and c o u l d p r o v e v e r y u s e f u l f o r c l i n i c a l 
d i a g n o s i s and e p i d e m i o l o g i c a l s u r v e y s . 
2 . Taxonomy 
The taxonomy of the species of the genus Leishmania 
represents a diverse group of kinetop 1 astid protozoan 
parasites grouped with Trypanosomes as 'Haemoflagellates'. 
The species of Leishmania - like parasites of lizards are now 
grouped in the genus Saurolei shman i a. Since there are few 
morphological differences among the various members of the 
genus Leishmania, therefore they are classified according to 
the clinical disease they produce. The different clinical 
forms given below have been taken from Report of a WHO Expert 
Committee, 1990. 
2.1 Old World Visceral leishmaniasis 
Visceral leishmaniasis is caused by parasites of the L. 
donovani complex. In visceral leishmaniasis, the disease 
tends to the chronic, and children especially are affected. 
The common symptoms are fever, malaise, shivering or chills, 
weight loss, anoorexia and discomfort in the left 
hypochondrium. Cough and diarrhoea occur less frequently. The 
common clinical sign are non-tender sp lenomegaly, with or 
without hepatomegaly, wasting and pallor of mucuous 
membranes; 1 ymphadenopathy may be present. In West Bengal, 
1 ymphadenopathy may be the only clinical manifestation. 
Darkening of the skin of the face, hands, feet and abdomen is 
often found in India (Chowdhury et al . , 1993). Frequently, 
from Sudan and occasionally from East Africa, the occurence 
of a cutaneous nodule or ulcer or a mucosal lesion, 
containing leishmanial parasites has also been reported 
(Perea et al . , 1991). Cases of visceral leishmaniasis are 
now more frequently reported from people having some kind of 
immunosuppression due to acquired immunodeficiency syndrome 
(AIDS) or chemotherapy or whatever. 
2.2 Old World cutaneous leishmaniasis 
Climcal features of cutaneous leishmaniasis tend to 
differ between and within the different geographical regions, 
reflecting the different species of parasites or the type of 
zoonotic cycle concerned, as also perhaps due to the 
genetically determined responses of the patient. A 
"classical" lesion starts as a nodule at the site of 
inoculation. A crust develops centrally, which may fall away 
exposing an ulcer which heals gradually, leaving a depressed 
scar with altered pigment. Satellite nodules at the edge of 
the lesion are common. 
2.3 Old World diffuse cutaneous leishmaniasis 
Diffused cutaneous leishmaniasis is caused by L. 
aethiopica and is characterized by widely disseminated 
thickening of the skin in plaques, papules or multiple 
nodules, appearing on face and exterior surfaces of the limbs 
and sometimes resembling like lepromatous leprosy nodules. 
2.4 New World visceral leishmaniasis 
The etiological agent of New World visceral 
leishmaniasis is L. chagasi. The major symptoms are similar 
to those of Old World visceral leishmaniasis. 
2.5 New World cutaneous leishmaniasis 
People in endemic areas have indigenous names for some 
forms of the disease like "Chiclero's ulcer" and "Pin-bois" 
caused by L. mexicana and L. guyanens i s respectively. In 
Chiclero's Ulcer, lesions occur generally on the face and 
ears (605t); mucous membranes are very rarely affected. A 
significant percentage of ulcerative lesions of the ear cause 
extensive destruction of the pinna. In Pian-bois, there is 
multiple ulcerative lesion in 60X patients; these often 
metabolize along the lymphatic channels producing multiple 
ulcers, which can stimulate sporotrichosis, spontaneous 
healing is extremely rare, and relapses are frequent. 
Primary cutaneous lesions are caused by L. brazil iensis 
where lymphatic spread and involvement of lymph glands are 
frequent, and spontaneous healing is rare. Reinfection is not 
common but it may occur; some patients develop a second 
cutaneous lesion at a different site after their primary 
infection has healed. Mucosal involvement is the most serious 
compli cation. 
2.6 New World diffuse cutaneous leishmaniasis 
New world diffuse cutaneous leishmaniasis is 
clinically and pathologically similar to Old World dermal 
cutaneous leishmaniasis. It has been associated only with 
membranes of the L. mexicana complex. 
2.7 New World mucocutaneous leishmaniasis 
Mucocutaneous leishmaniasis is caused by L. 
brazi 1 iensis or L. panamens i s. The characteristic of 
mucocutaneous leishmaniasis caused by these species is its 
propensity to metabolize the mucous tissues by lymphatic or 
haematogenous dissemination. 
3. Life Cycle 
The parasite has two stages in its life cycle, the 
amastigote form occurring in the mononuclear phagocytes of 
the r e t i c u l o e n d o t h e l i a l system of the mammalian host and the 
promast igote form occu r r i ng in the d i g e s t i v e t r a c t o f sand f l y 
v e c t o r , Phlebotomus sp. The amast igote of L. donovani i s a 
small n o n - f l a g e l l a t e d sphe r i ca l or ovo id body 2 to 4 jjm in 
leng th and 1-2 jjm in w i d t h . I t con ta ins a c e n t r a l nuc leus , a 
rod shaped k i n e t o p l a s t and a r u d i m e n t a r y n o n - f u n c t i o n a l 
f l a g e l l u m (Zukerman and L a i n s o n , 1977; Chang, 1 9 8 3 ) . The 
p r o m a s t i g o t e s a re l o n g s l e n d e r s p i n d l e - s h a p e d b o d i e s , 
measuring 15 to 20 jum in length by 1 . t o 2 xjm i n b r e a t h . 
K i n e t o p l a s t l i e s t r a n s v e r s e l y near t h e a n t e r i o r e n d , t h e 
nucleus i s s i t u a t e d c e n t r a l l y . The f l a g e l l u m may be of the 
same length as the body or even longer , p r o j e c t i n g from the 
f r o n t . The f l a g e l l u m does not curve round the body of the 
p a r a s i t e and t h e r e f o r e t h e r e i s no u n d u l a t i n g membrane 
( C h a t t e r j e e , 1982). 
The amast igo te form w h i l e r e s i d i n g i n t h e c e l l s o f 
r e t i c u l o e n d o t h e l i a l system, m u l t i p l i e s by b inary f i s s i o n . 
M u l t i p l i c a t i o n goes on con t inuous ly t i l l the c e l l becomes 
packed w i t h the p a r a s i t e . The host c e l l i s thereby en larged 
and even tua l l y rup tu res . The pa ras i t es l i b e r a t e d as a r e s u l t 
of the rup tu re i n t o the c i r c u l a t i o n , invade f r esh c e l l s and 
t h e c y c l e i s r e p e a t e d . I n t h i s way t h e e n t i r e 
r e t i c u l o e n d o t h e l i a l system becomes p r o g r e s s i v e l y i n f e c t e d . In 
t h e b l o o d s t r e a m , some o f t h e f r e e a m a s t i g o t e s a r e 
p h a g o c y t o s e d by t h e n e u t r o p h i l i c g r a n u l o c y t e s and 
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macrophages. A blood sucking fly draws these free amastigote 
forms as well as those within the macrophages during its 
blood meal. These amastigote forms develop into promastigote 
forms which again multiply by binary fission producing an 
enormous number of flagellates. Multiplication proceeds in 
the mid-gut of the sandfly and the flagellates tend to 
spread forward to the anterior part of the alimentary canal. 
A heavy pharyngeal infection of the sandfly is usually 
observed between the 6th and the 9th day of its infective 
blood meal. The transmission is thereby effected through the 
bite of the infected sandfly (Chatterjee, 1982). 
4. In vitro Cultivation 
The parasites, Leishmania, have been cultivated, in 
vitro, in liquid, semisolid or biphasic media enriched with 
blood or serum. The first culture medium of citrated blood 
for L. donovani was reported by Rogers in 1904. The NNN 
medium is a modified form given by Novy, Mac Neal and Nicolle 
(Nicolle, 1908a, b). This medium has been used in clinical 
laboratory practice for the last eighty years. It consists of 
blood agar and distilled water without peptone and beef 
extract. 
In 1928 Mayer and Ray used a defined Noller medium for 
cultivation of various leishmania parasites (Ray, 1932). This 
medium contained agar-agar and slightly alkaline Liebig's 
broth. Ray's medium developed in 1932 is still very popular 
because it is relatively simple in composition and, as such, 
easy to prepare and preserve. It contains an energy source, 
glucose, amino acid source, peptone, and an osmotic pressure 
stabilizer, sodium chloride. 
Another medium successfully employed for isolation and 
maintenance of various Leishmania species is blood beef agar 
and Locke's diphasic 'NIH medium' of Tobie et al, (1950) as 
modified from Salle and Schmidt (1928) and Senekje (1939). 
The NIH medium contains 30% defibrinated rabbit blood and is 
used for isolation of parasite from infected humans and other 
mammals. 
Contella (1968), Borysia (1968) and Clinton (1969) 
removed the cellular and other particulate components of 
blood by centrifugation or filtration through millipore 
filters, in order to get a liquid medium with high yield of 
clean promastigotes for antigen preparation and biochemical 
studies. Further modification of NIH medium was carried out 
by using 50 gms of bacto-beef instead of 25 gms and Hank's 
Balanced Salt Solution instead of Locke's Solution (Decker-
Jackson and Honigberg, 1978). A few semi-defined and non-
defined media, such as brain heart infusion (BHI) (Gaughan 
and Krassner, 1971) and NIH blood agar medium (Tobie et al , 
1950) are also widely employed for obtaining large number of 
parasites required for metabolic studies. Semi or non-
defined media are often used because they support the growth 
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more than the chemically defined media (Berens et al, 1976). 
L. donovai and L. branz i1iensis have been successfully 
grown on defined culture medium (REI) (Steiger and Steiger, 
1976). Cultures of L. donovani in REI medium are initiated 
with amastigotes from infected hamster's spleen or from 
promastigotes initially maintained in REI + ^0% fetal bovine 
serum. The generation time of L. donovani and L. 
branz i 1 iensis is reported as ^-^ 21.5 and 25 hours. The mean 
maximal cell yields are generally obtained on day 6 
(Stationary phase) --^  6x10 /ml for L. donovani and 3.5x10 /ml 
for L. branzil iensis. These parasites can also be grown in 
medium REI + 2.5 to 10X inactivated dialyzed fetal bovine 
serum. This medium was also found to support excellent growth 
of Trypanosoma rhodisiense and T. brucei (Steiger and 
Steiger, 1976). 
Another defined medium (HOSMEM - II) is a modification 
of semi-defined HOMEM medium. The 1056 fetal calf serum 
component of HOSMEM was replaced with vitamins, purine base, 
albumin mixture based on the defined medium REI (Steiger and 
Steiger, 1976), and H x 25 (Cross and Manning, 1973). The 
HOSMEM- II supports continuous growth after repeated 
subcultures. The medium is easy to prepare compared to REI 
medium. The growth characteristics of the parasite in this 
medium are identical to those reported for HOSMEM (Berens and 
Merr, 1978). 
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H e n d r i c k s (1975) r e p o r t e d t h e deve lopment o f a s i m p l e 
c u l t u r e m e t h o d u s i n g m o n o p h a s i c m e d i u m . E l e v e n 
h a e m o f 1 a g e l 1 a t e s p e c i e s i n c l u d i n g L, brazilienais and L. 
donovani we'^e c u l t u r e d i n t h e t i s s u e med ium t o w h i c h 305K 
f e t a l c a l f s e r u m was a d d e d . The t i s s u e c u l t u r e m e d i u m 
c o n t a i n e d 199 G r a c e ' s i n s e c t t i s s u e c u l t u r e med ium and 
S c h n e i d e r ' s D r o s o p h i l l a m e d i u m . S c h n e i r ' s i n s e c t c u l t u r e 
medium, however , was s i m p l e r t o use and was f ound h e l p f u l i n 
t h e d i a g n o s i s o f cu taneous l e i s h m a n i a s i s . I t was shown t o be 
more s u c c e s s f u l t han NNN medium ( H e n d r i c k s and W r i g h t , 1 9 7 9 ) . 
The S c h n e i d e r ' s i n s e c t c u l t u r e medium w i t h 3056 ( v / v ) h e a t 
i n a c t i v a t e d f e t a l bov ine serum p l u s 100 I . U . / m l p e n i c i l l i n 
and 100 j u g / m l s t r e p t o m y c i n was s i m p l e r t o u s e i n t h e 
d i a g n o s i s and management o f v i s c e r a l l e i s h m a n i a s i s i n Kenya 
(Hockmeyer e t a l , 1981) . 
NNN medium o v e r l a y e d w i t h S c h n e i d e r ' s medium was f o u n d 
more s e n s i t i v e t h a n e i t h e r NNN o r S c h n e i d e r ' s medium a l o n e 
f o r c u l t u r i n g L. donovani, e s p e c i a l l y f r om s p l e n i c a s p i r a t e s 
( G i t h u r e e t a l , 1 9 8 4 ) . T h i s med ium was a l s o f o u n d more 
s e n s i t i v e t h a n S c h n e i d e r ' s med ium a l o n e f o r d e t e c t i n g L. 
donovani i n c u l t u r e s made f r o m p e r i p h e r a l b l o o d (Chu lay e t 
a l , 1 9 8 5 ) . 
For c u l t i v a t i o n o f L. donovani, Rassam and A l - M u d h a f f a r 
(1980) used Panmede medium ( P a i n e s and Byrne L t d . ) . I t i s 
composed o f g l u c o s e , NaCl , KCl , d i s t i l l e d w a t e r , f e t a l c a l f 
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serum with penicillin and streptomycin sulphate. Ray and 
Ghose ( 19-80) developed a liquid culture medium (LDLC - II) 
for bulk cultivation of L. donovani promastigotes, in vitro. 
This medium was found to be relatively easy to prepare, 
yielding a number of parasites (4.3 - 105 x lo'/ml culture). 
The parasites grown in this medium were found free of any 
contamination and appeared suitable for immunological and 
related studies on leishmaniasis. The LDLC - II medium is 
composed of peptone, Hank's balanced salt soltuion, liver 
extract, normal rabbit serum and rabbit blood cell lysate to 
which streptomycin and penicillin are added. The culture 
time is around 10 -13 days. 
5. The Parasite antigen 
Parasite antigens are employed in the laboratory for 
various purposes such as vaccination, immunodiagnosis, 
analysis of immunopathology, and for quantitation of various 
immune responses in infected, vaccinated, or naturally 
resistant hosts. In the absence of defined antigens, little 
progress can actually be made towards understanding the 
immunological aspects of the host-parasite relationship. 
Hybridoma technology has provided a powerful new tool for the 
analysis and identification of parasite antigens (Mitchell 
and Cruise, 1981), and hopefully the use of recombinant DNA 
techniques for the production of protein antigens will be a 
major activity in the next decade. 
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Cook et al, 1969, have reported that Leishmania 
parasites constitute an antigenic mosaic. They demonstrated 
11 antigens in a lysate of L. mexicana. Similar results were 
obtained with L. donovani by Clinton et al , 1972. Dwyer 
(1976) has shown in his antibody cross absorption 
experiments that both promastigote and amastigote stages 
share common or cross reacting surface mambrane antigens. 
Each parasite form is known to contain unique-stage-specific, 
surface membrane antigens. Alongwith these cross-reacting 
surface antigens, four antigens common to promastigote and 
amastigote forms are also known to exist. These antigens were 
detected in cell free extracts of L. donovani (Simpson, 1968; 
Ghatak et al, 1982). 
Subcellular fractions of cell-free extracts showed that 
the maximum amount of such common antigens are present in the 
soluble supernatant. These supernatants were found to contain 
three types of antigens distinguished on the basis of their 
thermostability. These antigens donot share antigenic 
relationship with Mycobacteriurn and blood group antigens 
(Ghatak et al, 1982). 
Furthermore, Clinton and his colleagues recognized for 
the first time the existence of a soluble factor in the used 
medium from cultures of L. donovani promastigotes. This 
excreted factor (EF) was shown to be immunologically active 
in sensitized guinea pigs, as it produced a delayed skin 
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reaction andn was capable of precipitating anti-Leishmania 
antibodies raised in rabbit against living homologous 
promastigotes (Schnur et al , 1972a). Related and cell-
membrane-bound carbohydrate determinants have been cited as 
being important constituents of leishmania parasite (^ Jaffe et 
al . , 1990, McConville et al . , 1990; Singh et al . , 1990, Dc 
Majumdar, 199 2J. Surface carbohydrates of leishmania 
promastigotes are important for attachment to the 
macrophages (Blackwell, 1985; Turco, 1988) and sand fly 
digestive tract (Molyneux et al , 1986). Panels of lectins 
have revealed inter and intraspecific differences in 
promastigote surface sugar moities (Schottelius, 1982; Schnur 
and Jacobson, 1989). Released carbohydrates have also been 
shown to vary anti geni cal 1 y at the inter and i ntraspeci f i c 
levels, using polyclonal and monoclonal antibodies (Schnur, 
1982; Greenblatt et al, 1983). 
The EF of L. mexicana was used as an antigen for 
coating wells for modified ELISA and sheep red blood cell 
agglutination assays. The ELISA as tested against sera of LD 
positive patients was found much more sensitive than tanned 
red blood cell haemagglutination test. The EF also showed 
some cross reaction against sera of patients with malaria and 
amoebiasis. Thus the crude EF of L. mexicana which can be 
obtained in large quantities can serve as a suitaible and 
convenient antigen for large scale epidemiological surveys 
(Arora et al , 1985). Moreover, the existence of leishmanial 
exoantigen? ws detected by positive immunoperoxide staining 
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in the cytoplasm of Giant cells (infected with L. major) and 
non-parasitized epithelial cells (Sells and Burton, 1981). 
More recently, Jacobson and Schnur (1990) have shown 
that promasti gotes derived from the same clone of a well 
documented strain of L. major (LRC-L137) exhibit different 
carbohydrate configurations on their surface membranes and 
excrete different amounts, and possibly "types" of 
glycoconjugates in liquid and diphasic medium. 
The preparation of Leishmania antigen has been made in 
a diversified way according to their use and need, like some 
investigators have used whole parasite antigen, some 
particulate and some soluble antigen fractions (El-Amin et 
al, 1985; Obaid et al, 1989; Scott et al, 1987). For 
preparing freez-thawed antigen, the promastigotes from the 
log phase are first suspended in HBSS and frozen at -70°C and 
then thawed at 37°C. This procedure is repeated for three 
times. The criterion for the determination of promastigote 
death is the absence of parasite motility (Dwyer, 1976; 
Deckel—Jackson and Honigberg, 1978; Cook and Holbrook, 1983). 
The soluble and particulate antigen fractions are 
prepared by repeated centrifugation and washing of 
promastigotes followed by osmolysis in a sterilized distilled 
water at room temperature. The lysed suspension is 
centrifuged at 12000 x g for 30 min in a refrigerated 
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centrifuge (Jalees et al , 1981). Another method used by our 
laboratory (Obaid et al, 1985) utilizes the osmolysed 
parasite suspension, which is further centrifuged at 105, 000 
X 9 for one hour, to obtain soluble and particulate antigen 
fractions. Subcellular fractions are obtained by successive 
centrifugation of the cell free extract at 2000 x g for 10 
min, 12000 x g for 15 min and 105, ooo x g for 60 min. The 
sediments in this method include cell debris, nuclear 
fraction, mitochondrion, golgi apparatus etc. 
The detergent-free soluble fraction of promastigotes 
was prepared in the following way by Scott et al , 1987. The 
log phase promastigotes were sonicated in Trie buffer (p 
8.0) with protease inhibitors and centrifuged at 100, 000 x g 
for one hr. The soluble fraction was then collected and 
dialyzed against phosphate buffered saline. Since this 
antigen preparation was made to assess the protective 
immunity against L. major in BALB/c mice, therefore the 
candidate immunogens within the soluble antigen fraction were 
fractionated by anion exchange chromatography on Mono Q 
column where nine molecular fractions were obtained. 
Fractions 1 and 9 were capable of inducing protective 
immuni ty. 
More recently, a method for rapid purification of 
amastigotes of L. major and L. donovani was described by 
Glaser et al , 1990. They claim that this method is very 
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simple, gentle, rapid and gives complete purification of 
amastigotes of L. major and L. donovani from mouse lesions 
and hamster spleens, respectively. 
L. major amastigotes were purified from tail lesions 
in nude mice approximately after 4 to 4.5 weeks of infection. 
About four lesions were removed in 10 ml PBS-EDTA, Glu (PEG) 
buffer at 4°C (Jaffe et al, 1984). The PEG containing the 
lesions was poured over a fine wire mesh and a single cell 
suspension was made by gently forcing the material through 
the mesh with the flat end of a plunger from a 10 ml 
disposable syringe. The cell suspension was transferred to a 
glass Dounce homogenizer with a clearance of 60-90 >Jm and the 
amastigotes were released from host cells with seven thrusts. 
Centr i f ugation at 80xg for 5 min at 4°C pelleted large 
cellular debris. The supernatant was then centrifuged at 1300 
X g for 10 min at 4°C to pellet amastigotes. Pellets were 
resuspended in 10 ml of a fresh solution of ammonium 
chloride (168 mM) and were incubated at room temperature for 
10 min to lyse red blood cells. The ammonium chloride 
solution was diluted five folds in PEG and the parasites were 
collected by centrifugation as above. Amastigotes were 
resuspended in 10 ml PEG per two lesions and were 
sequentially filtered through polycarbonate filters of pore 
sizes 8,5 and 3 um using a gentle vacuum. The vaccum was 
adjusted to allow a flow of 50 ml aqueous solution through a 
25 mm filter with a 3 ,um pore size in 30 sec. Host cells and 
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cell debris were retained on the filters and parasites were 
collected in the filtrate. Amastigotes were washed twice with 
9 PEG before use. In these experiments 10 amastigotes were 
obtained from five lesions. 
The following variations were used for the purification 
of L. donovani amastigotes. PSGEMKA buffer (Hart et al, 1981) 
ws used instead of PEG. Up to two spleens from 8 weeks 
infected Syrian golden hamsters were ex-cised and diced. The 
material was transferred to a glass dounce homogenizer in a 
30 ml buffer and the parasites were released from macrophages 
with seven thrusts. After the centrifugation steps, red blood 
cells were lysed by incubation for 7 min in 0.05X saponin in 
PSGEMKA et 4°C. After one wash, amastigotes were resuspended 
in buffer (10 ml per spleen) and were filtered as described 
for L. major. 
6. Vacciniation Studies 
Numerous a t t e m p t s a t e x p e r i m e n t a l i m m u n i z a t i o n a g a i n s t 
l e i s h m a n i a s have been made. I n o c u l a u s e d f o r t h e p u r p o s e 
i n c l u d e d p a r a s i t e m a t e r i a l s s u c h as u l t r a s o n i c a t e d 
p r o m a s t i g o e s ( P r e s t o n and Dumonde, 1976 ) , dead p r o m a s t i g o t e 
a s s o c i a t e d w i t h a d j u v a n t ( H o l b r o o k and C o o k , 1 9 8 1 ) , 
p r o m a s t i g o t e s w i t h o u t an a d j u v a n t ( H o l b r o o k and Cook, 1 9 8 3 ) , 
Crude a n t i g e n - a n t i b o d y complex ( G r e e n b l a t t , 1 9 8 0 ) , s o l u b l e 
a n t i g e n ( S c o t t e t a l , 1 9 8 7 ) , l i v e p r o m a s t i g o t e s McGurn e t a l . , 
1 9 9 0 ; R i v i e r e t a l . , 1 9 9 3 ) and c h e m i c a l l y mu tagen ized a v i r u l e n t 
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promastigotes (McGurn, et a1, 1990). But satisfactory 
protection using any of the above formulation has not yet 
been achieved. However, 94% protection was observed with two 
intraperitoneal injections of 5 x 10 irradiated (150 Krad) 
promastigotes, the animals were capable of completely healing 
or controlling a challenge infection with L. major (Scott et 
al, 1987). Here the soluble antigen was prepared by 
centrifugation of sonicated log phase promastigotes at 100, 
000 X g for 4 hr. To identify the candidate immunogen within 
soluble antigen, the soluble antigen was further fractionated 
by anion exchange chromatography. In these experiments 
fraction 9 was most protective. This fraction contained a 
highly negative charged group of molecules, which represented 
less than ^% of the total protein found within fraction 9. 
An important question in vaccine development is how to 
accomplish preferential induction of the right antigen. 
Specific, CD4"*" T cell and CDS'*' T cell subsets were observed 
to enhanced the anti leishmani al activity of macrophages. 
Whilst receptor-mediated endocytosis of parasite antigens 
might readily lead to processing in acid endosomes and 
binding to major histocompatibility antigen complex (MHC) 
class II for presentation to CDA"^ T cells, since endocytosed 
antigen cannot be presented by MHC I molecule. Hence it is 
clear that antigen-specific CDS"*" T cells are generated during 
leishmanial infection and are important in the curing 
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response (playfair et a1, 1990). The demonstration by 
Engelborn and co-workers (1990) that IFN-r producing T cells 
generated during cure of leishmanias are able to recognise a 
broad range of leishmanial antigens suggesting that even 
though single molecule vaccines (eg, GP63, LPG) have met with 
some success in inbred mice, the search for a single major 
protective antigen for vaccination against leishmaniasis in 
man may be fruitless. In any case, polymorphism for MHC 
class I and class II molecule in genetically diverse human 
populations makes single antigen vaccine unattractive since 
some molecules may fail to bind the antigen for presentation 
to T cells. A recombinant vaccine ombining T cell epitopes 
for an array of protein antigens might therefore be more 
effecti ve. 
The Iranian group has admitted using 'leishmanization' 
because all other attempts to control the disease in 
some communities had failed. 'Leishmanization' is performed 
either by exposing certain areas of skin to sandfly bites 
or by scratching the skin area with material from active 
lesions. Technique was standardized when methods for 
culturing promastigotes became available but variability in 
size and duration of lesions resulting from the inoculation 
of virulent strains has caused the practice to be 
discontinued in Israel and Soviet Union. Any way, the spread 
of human immunodeficiency virus infection and the widespread 
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use of immunosuppressive drugs mean t h a t prospects f o r a l i v e 
vaccine are not good (Greenb la t , 1988). 
I m m u n i z a t i o n t r i a l s w i t h k i l l e d o r a t t e n u a t e d 
l e i shman ia p a r a s i t e s were a l s o c a r r i e d o u t i n l a b o r a t o r y 
animals w i t h v a r i a b l e reasons. Lainson and Bray (1964) found 
t h a t in t radermal i n j e c t i o n of mice and hamsters w i t h f o r m a l i n 
k i l l e d L. mexicana a m a s t i g o t e s w i t h F r e u n d ' s c o m p l e t e 
a d j u v a n t f a i l e d t o e l i c i t r e s i s t a n c e a g a i n s t p a r a s i t e 
cha l l enge . Lemma and Coole (1974) repor ted t h a t i n j e c t i o n of 
e rad ia ted L. enterietti i promast igotes i n guinea p igs f a i l e d 
t o e l i c i t p r o t e c t i v e i m m u n i t y a g a i n s t c h a l l e n g e w i t h 
un t rea ted organisms. In c o n t r a s t , Countinho (1954) found t h a t 
i n j e c t i o n of k i l l e d promast igotes produced a l i m i t e d degree 
o f p r o t e c t i o n i n g u i n e a p i g s a g a i n s t L. enteriettii. 
P a r t i c u l a t e f r a c t i o n of L. enterietti i i n Freund's complete 
ad juvant confer red a res i s tance aga ins t cha l lenge i n guinea 
p i g s , wh i l e c e l l sap f r a c t i o n s d id not s t i m u l a t e p r o t e c t i v e 
immunity (Preston and Dumonde, 1976). Immunogenic enhancement 
w i t h app rop r ia te immunomodulating agents , which e s p e c i a l l y 
enhance the host defense mechanisms, may thus be r equ i r ed t o 
e l i c i t p r o t e c t i v e immunity. 
A number of immunoadjuvants l i k e Glucan (Obaid e t al , 
1989), BCG (Conv i t e t a l , 1987; Costa e t a l , 1988), Freund's 
c o m p l e t e a d j u v a n t ( P r e s t o n and Dumonde, 1976) and 
Corynbacterium parvum (Sco t t e t a l , 1987) have been used f o r 
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v a c c i n a t i o n a g a i n s t Les ihamia w i t h v a r y i n g s u c c e s s . More 
r e c e n t l y , BCG has been used as a r o u t i n e immunomodulator. BCG 
a l t e r s the balance of suppressor t o he lper c e l l s , p e r m i t t i n g 
g rea te r macrophage a c t i v a t i o n and lead ing t o rap id c learance 
o f p a r a s i t e , BCG i n c r e a s e s t h e r e s i s t a n c e o f m u r i n e 
macrophages to Trypanosoma cruzi as demonstrated by in vitro 
t e s t (Ho f f , 1975). BCG has a lso been shown to induce complete 
p r o t e c t i o n against a f a t a l s t r a i n o f Babesia (C la rk e t a l , 
1976) . But i n d u c t i o n of n o n - s p e c i f i c r e s i s t a n c e a g a i n s t 
p r o t o z o a l i n f e c t i o n s us ing BCG has n o t been u n i f o r m . For 
example, BCG f a i l e d to p r o t e c t c a t t l e aga ins t Babesia. When 
the s t r a i n of mice or species of ma la r ia was va r i ed d i f f e r e n t 
r e s u l t s were o b t a i n e d . The i n d u c t i o n o f n o n - s p e c i f i c 
r e s i s t a n c e i s a complex p rocess t h a t depends on s e v e r a l 
c h a r a c t e r i s t i c s o f t h e ' i n d u c e r s ' , t h e h o s t , and t h e 
cha l lenge organisms (Mahmoud, 1982). 
Due t o s u c c e s s o f BCG as an i m m u n o m o d u l a t o r , i n 
Venezuela, Convi t e t a l , (1987) have shown t h a t i n t raderma l 
i n o c u l a t i o n of l i v e BCG toge ther w i t h h e a t - k i l l e d le ishmania 
p r o m a s t i g o t e s p rov i ded e f f e c t i v e immunotherapy a g a i n s t 
l o c a l i s e d cutaneous l e i shman ias i s . Three vacc ina t i ons over 32 
weeks gave a s i m i l a r cure ra te (94^) t o th ree 20-day courses 
of meglumine ant imonate. 
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7. Immune Responses 
Most c l i n i c a l and e x p e r i m e n t a l o b s e r v a t i o n s s u g g e s t 
t h a t immune r e s i s t a n c e t o l e i s h m a n i a s i s i s l i n k e d t o c e l l -
m e d i a t e d i m m u n o l o g i c a l p r o c e s s e s , a l t h o u g h c e l l - b o u n d 
a n t i b o d i e s may i n f l u e n c e t h e e x p r e s s i o n o f t h i s c e l l u l a r 
r e s p o n s e ( B r y c e s o n 1 9 7 0 a ) . I n man, t h e i n d u c t i o n o f c e l l -
m e d i a t e d immuni ty depends upon t h e i m m u n o l o g i c a l competence 
o f t h e h o s t and v i r u l e n c e o f t he i n f e c t i o u s a g e n t . S i n c e , 
c e 1 1 -med1 a t e d immune r e s p o n s e s p e r s i s t f o r many y e a r s 
f o l l o w i n g r e c o v e r y f r o m an i n f e c t i o n ( W y l e r e t a l , 1 9 7 9 ) , 
t h e r e f o r e an i n c r e a s i n g number o f p a t i e n t s w i t h a c q u i r e d 
immune d e f i c i e n c y syndrome (AIDS) o r o t h e r fo rms o f immune 
d e f i c i e n c y a re be ing r e p o r t e d t o s u f f e r f r om r e c r u d e s c e n t 
l e i s h m a n i a s i s (Bada ro e t a l , 1 9 8 6 ; A n t u n e s e t a l , 1 9 8 7 , 
Grammicc ia e t a l . , 1992) . However, one o f the i m m u o l o g i c a l 
h a l l m a r k s o f v i s c e r a l l e i s h m a n i a s i s i s a r emarkab le i n c r e a s e 
i n serum immunog lobu l i ns m o s t l y o f t h e IgG and IgM c l a s s e s 
( G h o s e e t a l , 1 9 8 0 ) , c a u s i n g a r e v e r s a l o f t h e 
a l b u m i n / g l o b u l i n r a t i o ( I r u n b e r r y e t a l , 1968; Rezai e t a l , 
1 9 7 8 ) . F u r t h e r m o r e , m o s t p r e v i o u s s t u d i e s on v i s c e a r l 
l e i s h m a n i a s i s have been c a r r i e d o u t i n r o d e n t h o s t s , and 
a l t h o u g h s i g n i f i c a n t advances have been made due t o t h e s e 
s t u d i e s s , t h e p r e c i s e mechanisms of p r o t e c t i v e immun i t y 1n 
v i s c e r a l l e i s h m a n i a s i s r e m a i n s u n r e s o l v e d a n d p o o r l y 
u n d e r s t o o d (Gross e t a l . , 1992; F rankenburg e t a l . , 1 9 9 3 ) . 
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7.1 Cellular Immune Responses 
Protection and immunity in leishmaniasis is generally 
conceded to be predominantly eel 1-mediated (Garnham and 
Humphrey, 1969; Zuckerman, 1975), and may be via different 
mechanisms. Furthermore, there is ample evidence that the 
mechanism of recovery against subsequent infection also has 
an immunological basis. The cutaneous ulcer caused by L. 
tropica usually remains confined to the skin at the site 
where an infected fly bites. Patients recovering from 
uncomplicated old world cutaneous infection or from similar 
infections caused by Leishmania species of the New World, 
achieve radial cure and acquire solid, long lasting immunity 
against reinfection by the homologous organisms (Heyneman 
1971; Mackelt 1972). Rare cases of reinfection or relapse 
have been documented (Guirges, 1971), particularly after 
immunosuppressive therapy. Similarly, spontaneous or drug 
induced healing of the visceral infection lead to such an 
excellent degree of immunity that true second attacks are 
unknown (Manson-Bahr, 1961). 
Nacy et al (1981) have demonstrated in vitro killing of 
macrophage infected L. tropica by lymphokines. Lymphokine 
treated macrophages developed two potent antimicrobial 
activities such as increased resistance to infection by L. 
tropica amastigotes and inhibition of replication and 
ultimate killing of intracellular parasite. Reed et al. 
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(1984) also showed that mice infected with L. donovani and 
treated with lymphokine-rich supernatants (encapsulated in 
liposomes) have significantly fewer parasites in the liver 
than the control group, demonstrating an in vivo activity of 
lymphokines against an infected organism. 
More recently, Sypek and Wyler (1990) using lymph node 
lymphocytes of L. major-infected mice constructed and cloned 
2 T-cel1 hybridomas that could activate macrophages to exert 
antileishmanial defense in vitro. One clone, 1D5, produced 
lymphokines (including gamma interferon) that induced these 
affects. Production of macrophage activating lymphokines and 
the protective effect of 1D5 were suppressed by the addition 
of Cyclosporin A to cultures. The other clone, 1B6, produced 
no detectable macrophage activating lymphokines, and its 
protective activity/ability was not suppressed by Cyclosporin 
A. Moreover, neither clone was cytotoxic to the infected 
macrophages. 
Mouse peritoneal macrophages were infected with 
Leishmania parasites from different species and were exposed 
to different electron carriers like methylene blue (MB), 
toluidine blue (TB), phenazine methosu1phate (PMS) and 
Crystal violet (CV). This led to killing of the intracellular 
parasites with no harm to macrophages. On a molar basis, the 
potency of electron carriers decreased in the following 
order: CV, TB, MB and PMS. MB and TB were more active against 
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i n t r a c e l l u l a r compared to f r e e p a r a s i t e s , suggest ing t h a t the 
macrophages themselves m igh t p l a y a r o l e i n t h e o b s e r v e d 
a n t i - p a r a s i t e t o x i c i t y . No d i f f e r e n c e c o u l d be d e t e c t e d 
between macrophages from d i f f e r e n t mouse s t r a i n s as regard t o 
t h e i r c a p a c i t y t o k i l l i n t r a c e l l u l a r p a r a s i t e s upon 
i ncuba t i on w i t h e l ec t r on c a r r i e r s . When macrophages from L. 
tropica s u s c e p t i b l e ( n o n - h e a l e r ) BALB/c mice s t r a i n were 
i n f e c t e d w i t h e i t h e r L. enrittii o r L. major, and t h e n 
e x p o s e d t o an a c t i v a t i n g l y m p h o k i n e r i c h s u p e r n a t a n t , 
. d e s t r u c t i o n of on ly L. enrittii was a c h i e v e d whereas L. 
major su rv ived i n t r a c e l l u l a r l y . I ncuba t i on w i t h MB, however, 
led to i n t r a c e l l u l a r d e s t r u c t i o n of both p a r a s i t e s . Other 
Leishmania species could a lso be k i l l e d i r r e s p e c t i v e of the 
gene t i c background of the macrophages. These observa t ions 
suggested t h a t the t r i g g e r i n g events i n e l e c t r o n c a r r i e r and 
lymphokine mediated i n t r a c e l l u l a r k i l l i n g were d i f f e r e n t 
(Mauel 1984). 
The . d e s t r u c t i o n o f p a r a s i t e s w i t h i n macrophages i e 
presumably mediated by t o x i c me tabo l i t es of oxygen, which may 
induce the superoxide anion (O2), hydrogen perox ide (H202)i 
s i n g l e t oxygen ( IO2) or h y d r o x y l r a d i c a l s (HO) ( J o h n s t o n 
1978) . Th is idea has been w e l l documented i n t h e case o f 
Toxoplasma gondii i n f e c t i n g mouse macrophages (Murray e t a l 
1979). A s i m i l a r s i t u a t i o n may occur in Leishmania i n f e c t i o n , 
as i t i s w e l l e v i d e n c e d by t h e e x p e r i m e n t s o f some 
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investigators (Buchmuller and Mauel, 1981; Klebanoff, 1967; 
Schnyder and Baggliolini, 1980; Frankenburg, Kofsky and 
Gross, 1993) . 
7.2 Humoral Immune Responses 
Ample evidiences from clinical and experimental studies 
are available to suggest that antibodies are .capable of 
inducing parasite phagocytosis by macrophages (Herman, 1980). 
The humans completely cured of visceral leishmaniasis 
develop a strong Arthus reaction at the intradermal site 
where L. donovani are reinoculated. Parasites are not 
recovered at the site of challenge inoculum, and this 
reaction rapidly disappears (Manson-Bahr 1961). The high 
titres of class-specific antibodies and the enhanced CMI 
responses (Dennis 1984) after reinoculation of L. donovani 
into squirrel monkeys are marked with subsequent decrease in 
parasite densities in the liver. 
In studieis of Das et al (1989) it was demonstrated 
that the killing of 7. donovani promastigotes is antibody 
mediated. Immune serum raised against flagellar fraction of 
L. donovani isolate, UR6, has profound lethal effect on the 
in vitro growth of parasite. Lethal effect of immune serum 
was also examined using two other isolates of L. donovani, 
namely DD8 and AG83. It was observed that immune serum is 
equally effective against UR6 and DD8, but has no effect on 
AG83 promastigotes. Furthermore, parasite killing is mediated 
by Leishmania specific antibodies in the absence of 
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complement or any other factor present in rabbit serum. These 
results also indicated that the lethal effect of immune serum 
was due to impairment of membrane function, leading to 
inhibition in the uptake of essential nutrients needed for 
growth and survival of parasites. 
Several workers have assayed the elicited humoral 
immune responses following vaccination of animals (Scott et 
al . , 1987; Jaffe et al . , 1990), in order to measure the 
extent of immune protection afforded by such procedures. The 
antibodies appear to directly participate as immune effectors 
in vaccine-induced immunity since high levels of circulating 
antibodies are detectable after i.p. or i.v. immunizations 
(Howard et al., 1982). Scott et al (1987) have detected 
antibodies against intracellular antigens in BALB/c mice 
immunized with L. major soluble antigens. The soluble 
antigens were further fractionated in order to identify the 
candidate immunogen(s) within this antigen fraction. They 
indicated that antigenic moieties within fraction 9 of the 
soluble antigen, are recognized by antibodies in the 
immunized mice, suggesting a definite role of humoral 
immunity in protection. 
In fact, some antibody mediated protection has been 
desmonstrated with monoclonal antibodies that are directed 
against leishmanial surface antigens (Anderson et al, , 1983). 
Hu et al. , 1989 have raised monoclonal antibodies (McAb) 
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against membrane antigen of promastigotes of L. donovan i 
canine isolate. 
They reported 3 McAb which inhibit the growth of 
promastigotes in culture. Monoclonal antibodies such as 2B12-
A8 and 2H6-E3 showed strong inhibiting effect in the presence 
of complement. The inhibiting range fluctuated between 68-
95%, and this inhibition was further confirmed by means of 
macrophage inhibition test. Moreover, the results of 
ultrastructural localisation of L. donovan i antigen by 
protective McAb, 2H6-E3, with immunogold technique showed the 
gold particles in clumps widely distributed on the outer side 
of promastigote membrane. According to the high density of 
localised gold particles, it is suggested that antigen is 
localised on the plasma membrane. 
In visceral leishmaniasis specific anti1eishmani a 1 
antibodies are produced in humans (Badaro et al, 1983; 
Edrisson et al . , 1981), Owl monkeys (Broderson, 1982), 
hamsters (Campos-Neto and Bunn-Moreno 1982) and mouse 
(Kripatrick and Farrell 1982). Low IgM and IgG titres of 
class-specific antibodies have been reported from some cases 
of human visceral leishmaniasis (Ghose et al, 1980). Also, 
studies of Dennis et al , 1986 on infected squirrel monkeys 
showed production of IgM and IgG class-specific antibodies. 
IgG titres were found to be higher than IgM titres in the 
plasma from these monkeys. 
30 
In human visceral leishmaniasis, the major increase in 
serum Y-globulins is nonspecific for Leishmania spp. No 
correlation is observed between the increase in serum V -
globulins and the production of specific anti1eishmania 1 
antibodies (Zuckerman 1975), However, in studies of Dennis et 
al, 1986 on infected squirrel monkeys, a correlation was 
noted between increased V-globulin levels and raised levels 
of immunoglobulins (IgM and IgG) but not between V-globulin 
concentration and specific anti1eishmania 1 antibodies. 
Conversely, a correlation was observed between increased 
levels of Y -globulin (immunoglobulin), IgM and IgG levels, 
and the production of IgG class specific antileishsmanial 
antibodies in squirrel monkeys challenged with L. donovani. 
Much of the increased IgG appears to be specific to L. 
donovani. The study was used to compare the primary infection 
against challenged animals. 
8. Macrophage - Parasite Relationship 
Intracellular parasitism is a common feature of several 
parasitic protozoa that cause tropical disease. A remarkable 
example is Leishmania, whose amastigote stage exclusively 
parasitizes macrophages (Mononuclear phagocytes), which is 
one of the principal cell types responsible for cellular 
defense against invading microorganisms. The ability of 
amastigotes to live in macrophages is due to an intracellular 
symbiosis of leishsmania. For establishing such intracellular 
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symbiosis for sequential events are important: recognition, 
intracellular entry, survival and multiplication (Moulder 
1979b). Leishmania - macrophage interaction has been studied 
by infecting eritoneal.macrophages in vivo and in vitro with 
L. donovani (Olivier and Tanner, 1887; Olivier et al , 1989, 
Lytton, Mozes and Jaffe, 1993). 
The binding of leishmania to macrophages was studied in 
vitro by light microscopy. It was found that a large number 
of promastigotes become attached to the cells in relatively 
short time (Chang, 1981a). This binding was suggested to be 
mediated by discrete membrane molecules but not through non-
specific interaction (Chang, 1979), It was also found that 
binding of L. donovani promastigotes to hamster peritoneal 
macrophages is a ligand receptor interaction involving 
antigenic surface membrane proteins. Thus the receptor 
mediated gains entry into macrophages (Chang 1981a). 
The entry of leishmania parasites into macrophages 
depends on the phagocytic activity of these cells and the 
motility of the organisms. There is no specific orientation 
during this entry (Chang,1979). A number of studies suggested 
that parasites reside within a vaculoe of host cell origin, 
and that lysosomes do fuse with these parasitophorous 
vacuoles soon after infection (Alexander and Vickerman, 1975, 
Chang and Dwyer, 1976; 1978). 
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Chang and Fong (1983) have also reported similar 
findings from L. donovani hamster macrophages in an in vitro 
system. Amastigotes are first loodged in phagosomes which are 
subsequently fused with the secondary lysosomes. The ability 
of leishmania parasite to live in the secondary 1ysoosomes of 
the macrophages mmay be due to certain intrinsic structures 
and dynamic properties of the parasite plasma membrane. 
Leishmania parasites undergo plasma membrane related changes 
on entry into macrophages at the morphological, antigenic and 
molecular levels. Most of these changes probably reflect 
necessary steps for the transition of parasites from an 
extracellular to an intracellular life. 
It was also proposed that survival of leishmania 
parasites in macrophages must be based on the resistance to 
enzymatic degradation into lysosomes and to the microbicidal 
factors present in the intracellular macro-environment 
(Chang, 1983). There may be two possibilities for the 
resistance of leishmania to lysosomal enzyme degradation: (I) 
Leishmania may have a naturally resistance surface to 
lysosomal enzyme degradation (Chang and Dwyer, 1976). (II) 
Leishmania may release factors which act as enzyme inhibitors 
(El-on et al , 1980; Theodo's et al . , 1991), or change the 
intralysosomal pH (Coombs, 1982). 
Studies f-elated to the infection of various inbred 
strains of mice by L. donovani have demonstrated that innate 
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resistance to this intracellular parasite seems to be 
controlled by a single gene (Lsh), which maps on chromosome 1 
(Bradley et al, 1979). Many in vivo studies have 
demonstrated that T cells are ineffective in regulating the 
expression of this gene, which also controls infection by 
other intracellular pathogens (Bradley and Kirkley, 1972; 
O'Brien and Metcalf, 1982; Skamena et al, 1982; Hoermache et 
al, 1983; Ulezak and Blackwell, 1983). T-lymphocytes have not 
been shown to have any regulating effect on the expression of 
the Lsh gene. But the importance of T cells in the 
elimination of L. donovani in C57BL/C mice has been well 
documented by Skov and Twohy (1974). Recently, Reiner and 
Finke (1983) and Reiner (1987) showed that the production of 
interleukin (IL)-1 and IL-2 by BALB/c mice cells is inhibited 
during infection in in vitro and in vivo systems Murray et 
al. (1987) have reported that the infection reduces the 
capacity of animals to produce interferon (IFN)-gamma. These 
findings clearly demonstrate that the infection while 
suppressing several immunological functions of macrophages 
permits the establishment of the parasites. Murray et al. 
(1982) have also shown that level of parasitism seems to be 
inversely related to the ability of the organisms to 
stimulate the production of macrophage activating lymphokines 
by T eel Is. 
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9. Pathology 
Desp" ' te t h e w ide range o f m a n i f e s t a t i o n s seen i n 
l e i s h m a n i a l i n f e c t i o n s , a l l c l i n i c a l and g e o g r a p h i c a l 
v a r i t i e s of the disease share a common h i s t o l o g i c a l f e a t u r e , 
namely, the e a r l y accumu la t i on o f mononuc lea r p h a g o c y t i c 
c e l l s ( o r h y p e r p l a s i a ) i n t h e i n v a d e d t i s s u e . The 
dermato log ic species induces an i n i t i a l h i s t i ocy toma in the 
s k i n , wh i le the v i s c e r o t r o p i c species induces hype rp las ia of 
r e t i c u l o e n d o t h e l i a l c e l l s o f t h e o r g a n s i n v a d e d . The 
p a t h o l o g i c a l changes t h a t c h a r a c t e r i z e the va r ious c l i n i c a l 
forms of the d isease r e f l e c t t h e b a l a n c e between p a r a s i t e 
m u l t i p l i c a t i o n , the immune response of the p a t i e n t and the 
r e s u l t a n t d e g e n e r a t i v e changes ( R e p o r t o f WHO E x p e r t 
Committee, 1990). V isce ra l l e i shman ias i s , k a l a - a z a r , occurs 
in a l l age groups. I t i s c h a r a c t e r i z e d by f e v e r , anaemia, 
reduced whi te c e l l count , was t i ng , splenomegaly and serum 
p r o t e i n imbalances. I t usua l l y ends up f a t a l l y , i f remains 
u n t r e a t e d . In I n d i a n k a l a - a z a r , a p o s t k a l a - a z a r derma l 
l e i s h m a n i a s i s occurs in some i n d i v i d u a l s a f t e r t r e a t m e n t 
(Zuckerman and la inson 1977). 
V i s c e r a l l e i s h m a n i a s i s may be m a n i f e s t e d as a m i l d , 
s e l f l i m i t i n g , asymptomatic or o l igosymptomat ic i n f e c t i o n , 
and o n l y a smal l f r a c t i o n of i n f e c t e d i n d i v i d u a l s d e v e l o p 
p rog ress ive disease (Gu t i e r rez e t a l , 1984). Se l f l i m i t i n g 
i n f e c t i o n s are fo l lowed by a long l a s t i n g immunity. As long 
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term immunity requires the presence of antigens, it is 
beleived that Leishmania (or some antigens thereof) must 
persist for long time following the original infection. The 
hypothesis that live leishmanias persist in apparently normal 
individuals is supported by the observation that increasing 
number of immunosuppressive patients, such as those of AIDS 
or those undergoing immunosuppressive therapy for cancer, are 
also found to suffer from visceral leishmaniasis with no 
known history of the disease. Hence, a state of premunition 
(balanced immunity and concurrent infection) apparently 
exists following the initial infection, and the depression 
of protective immunity shifts the balance in favour of 
parasite. On the basis of these observations, along with the 
demonstration of live parasites in mouse long after 
spontaneous healing of the lesions, it has been suggested 
that in certain cases visceral leishmaniasis may be 
considered as an opportunistic infection (Report of WHO 
Expert Committee, 1990). 
A histiocytic proliferation with increasing parasite 
load is responsible for the early phase of hepatomegaly. The 
addition of 1ymphop1asmacytic elements aggravate the 
situation of the later stages. Histopathological changes of 
these organs involve necrosis apparently due to the lysis of 
parasitized histiocytes and granuloma formation which, as in 
cutaneous leishmaniasis, may be a post-necrotic phenomenon. 
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All these changes apparently result from host immune 
responses (Mauel and Behlin 1982). 
Pencytopenia is particularly marked by a reverse 
haemolytic anaemia which is considered to be the most 
important contributory factor for the fatality of kala-azar. 
Thrombocytopenia and leucopenia may be moderate to severe. 
The actual mechanism triggering these haemocytopathic changes 
is not well understood, hypersplenism and lysis through an 
autoimmune reaction have been proposed (Woodruff et al, 1972; 
Musumeci et al, 1974a; Russo 1977). Isotopically labelled red 
cells and platelets were shown to have reduced life span in 
kala-azar patients and hyperactivity of the spleen was 
thought to be responsible for their destruction. But the 
rapid reversal of haemolytic activity by antimony treatment 
is not quite compatible with this idea, since antimonials 
donot suppress haemolytic activity in the anaemic conditions 
such as thaiassaemia, in which incureased activity of the 
reticuloendothelial system is also very evident (Musumeci et 
al, 1974b). 
The histopathology of different organs involved in 
visceral leishmaniasis has been described by many authors 
(Ritterson 1955; Duarte et al , 1983; Duarte and Corbett 1984, 
1987; Gutierrez et al 1984; Correa et al., 1992), but 
little is known about the cutaneous changes which 
occur after parasite inoculation by the sandfly. 
Susceptibility to lysis decreases during growth 
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of the organisms in cultures or in the sandfly. The chances 
that leishmania parasites will enter the target cells are 
greatly increased because they bind to target cells at 
multiple receptor sites. It has been shown that the salivary 
glands of sandflies contain potent inflammatory agents which 
enhance the infectivity of promastigotes in the mouse (Report 
of WHO Expert Committee 1990). Finally, infective macrophages 
have been shown to produce colony stimulating factors which 
stimulate precursor cells thereby providing new target cells 
for the parasite. 
The most important immunopathological feature of kala-
azar is haemolytic anaemia (Aksoy et al , 1970; Bray and 
Wilson 1972), in which the life span of erythrocytes is 
reduced during an active febrile disease (Woodruff et al, 
1970; 72). The anemia is thought to be of an autoimmune 
nature. Red cell destruction occurs mainly in the spleen. The 
splenectomized patient is not generally anemic (Woodruff et 
al, 1972; Woodruff 1973). Other changes include 
thrombocytopenia and prothrombin depletion, intestinal 
ulceration, myocardial damage, amyloidois and cloudy swelling 
of the liver (Pampiglione et al , 1974). Leucopenia due to 
absolute reduction in all forms of granulocytes with moderate 
increase in lymphocytes and monocytes was found as a usual 
feature in kala-azar (Aikat et al, 1979; Manson-Bahr 1971). 
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The repor t of WHO Expert Committee (1984) exp la i ns t h a t 
hypoalbuminaemia is assoc ia ted w i t h oedema and o ther f ea tu res 
o f m a l n u t r i t i o n . I n t h e advanced s t a g e , i n t e r c u r r e n t 
i n f e c t i o n such as pneumonia, dysentery and t u b e r c u l o s i s are 
q u i t e f r equen t . These are usua l l y the common causes of death 
in l e i shman ias i s . However, exper imenta l l e i i s h m a n i a s i s in 
golden hamsters r e s u l t s i n splenomegaly and hepatomegaly. 
Maximum a v e r a g e e n l a r g e m e n t o f t h e l i v e r i s , h o w e v e r , 
compara t ive ly of a lesser order than the sp leen . Anemia and 
l e u k p e n i a w i t h marg ina l l y m p h o c y t o s i s , and w i t h o u t any 
c o n c u r r e n t i nc rease in monocytes a re some o t h e r f e a t u r e s 
(Ja lees e t al 1981). 
10. Drug Therapy 
Al though s i g n i f i c a n t advances i n the Chemotherapy of 
l e i s h m a n i a s i s have been made, b u t a l a r g e number o f 
chemotherapeut ic agents c u r r e n t l y a v a i l a b l e have a number of 
draw backs such as h igh t o x i c i t y , i n c l u d i n g a s i g n i f i c a n t 
number o f chemotherapeu t i c f a i l u r e s ( S t e c k , 1972, 1 9 7 4 ) . 
Recent l y , the TDR le ishman ias is u n i t has documented the f i r s t 
e v e r l a r g e - s c a l e c l i n i c a l r e s i s t a n c e o f k a l a - a z a r t o 
an t imon ia l drugs. C l i n i c a l cases r e s i s t a n t t o an t imon ia l s are 
r e a c h i n g an a l a r m i n g p r o p o r t i o n s i n I n d i a . T h e r e a r e 
i n d i c a t i o n s f rom the s t a t e o f B i h a r i n I n d i a , t h a t abou t 
10000 cases were unresponsive to antimony t rea tment out of 
200 000 repor ted (TDR news, 1990). The a v a i l a b i l i t y of b e t t e r 
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and newer chemotherapeutic or immunotherapeutic agents is 
obviously required for the treatment of infections caused by 
Leishmania parasites. 
Pentavalent antimony in the form of sodium 
stibogluconate (Pentostam) or maglumlne antimonate 
(Glucantime) is the chief chemotherapeutic agent which has 
been used since approximately 1945 (Berman and Grogl, 1988). 
Extensive studies have been carried out on different aspects 
of these pentavalent antimonial drugs. Convit et al , 1987 
have reported 94S^  cure rate in humans by three 20-day courses 
of meglumine antimonate. 
White et al, 1989 have indicated that the opossum is an 
animal model which is markedly susceptible to visceral 
leishmaniasis (Hanson et al , 1980). Due to this marked 
susceptibility, chemotherapy studies were performed to 
determine the efficacy of meglumine antimonate and WR 6062, 
an 8-aminoquinoline derivative, in the treatment of visceral 
leishmaniasis and, to evaluate the potential of this host in 
the chemotherapy of visceral leishmaniasis. These results 
indicated that both the drugs were effective in the 
suppression of amastigotes in the liver and spleen of 
opossums. Despite the marked suppression of parasites in the 
liver and spleen of infected opossums, the experimental 
disease was fatal in all the infected animals inspite of the 
therapy. 
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P e n t a m i d i n e i s c l i n i c a l l y e f f e c t i v e b u t has b e e n 
r e g u l a t e d t o t h e s t a t u s o f a s e c o n d a r y a g e n t b e c a u s e o f 
t o x i c i t y . H o w e v e r , p e n t a m i d i n e i s a w i d e l y e m p l o y e d 
a n t i m i c r o b i a l because i t i s a l s o e f f e c t i v e i n Pneumocyctis 
carinii i n f e c t i o n s and i n A f r i c a n T r y p a n o s o m i a s i s . B o t h 
P e n t o s t a m and p e n t a m i d i n e a r e m o r e a c t i v e a g a i n s t 
i n t r a m a c r o p h a g e a m a s t i g o t e t h a n e x t r a c e l l u l a r p r o m a s t i g o e s 
(Berman e t a l , 1980, Thakur e t a l . , 1993 ) . Both t hese d r u g s , 
i n g e n e r a l , a r e more a c t i v e a g a i n s t a m a s t i g o t e s t h a n 
mammalian ee l 1s. 
U p t a k e o f p e n t o s t a m by c e l l s c a n be v i a s i m p l e 
d i f f u s i o n , f a c i l i t a t e d d i f f u s i o n , o r a c t i v e t r a n s p o r t . The 
e x p e r i m e n t s o f Berman e t a l , 1987 h a v e d e m o n s t r a t e d t h a t 
a m a s t i g o t e s , c o m p a r e d t o p r o m a s t i g o t e s a n d m a m m a l i a n 
m a c r o p h a g e s , c o n c e n t r a t e m o r e p e n t o s t a m , s u g g e s t i n g a 
machanism t h a t may c o n t r i b u t e t o w a r d s t h e t o x i c i t y o f t h e s e 
d rugs t o a m a s t i g o t e s compared t o p r o m a s t i g o t e s o r mammalian 
macrophages. 
D a r o u t i and R u b a i e ( 1 9 9 0 ) u s e d a c o m b i n a t i o n o f 
i n t r a l e s i o n a l s t i b o g l u c o n a t e i n f e c t i o n and s u p e r f i c i a l 
c r y o t h e r a p y i n an a t t e m p t t o i m p r o v e t h e t h e r a p e u t i c 
e f f i c a c y o f e i t h e r o f t hese two m o d a l i t i e s when used i n t h e 
t r e a t m e n t o f cu taneous l e i s h m a n i a s i s . T h i s combined t h e r a p y 
r e s u l t e d i n a 100% cure r a t e i n 15 p a t i e n t s w i t h 23 l e s i o n s 
o f cu taneous l e i s h m a n i a s i s . The r e s u l t s o b t a i n e d by combined 
s u p e r f i c i a l f r e e z i n g a n d i n t r a l e s i o n a l s t i b o g l u c o n a t e 
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injection were much more impressive than those obtained by 
each of the two modalities used singly. 
Although it is generally accepted that pentavalent 
antimonials are the standard first-line drugs, there is much 
variation in their use. The two pentavalent antimonials, 
sodium stibogluconate and meglumine antimonate are chemically 
similar and their toxicity and efficacy in visceral 
leishmaniasis are thought to be related to their content of 
pentavalent antimony (Sb ). Meglumine antimonate solution 
contains about 8.5X Sb (85 mg/ml), whereas sodium 
stibogluconate solution contains about ^0% Sb (100 mg/ml). 
Treatment with antimonials is well tolerated, but if serious 
side-effects arise it may be prudent to interrupt the course 
of treatment temporarily. If relapses occur, patients should 
first be treated again with an antimonial. If the response is 
still unsatisfactory, or in cases of primary 
unrersponsiveness, the second-line drugs are amphotericin B 
and Pentamidine (Report of WHO Expert Committee, 1990). 
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AIMS AND OBJECTIVES 
Leishmaniasis is a parasitic disease that poses a major 
health problem in a large number of countries. Around the 
world some 350 million people per year are at risk of 
acquiring the infection, whereas approximately 12 million 
people are already infected. Though enormous efforts have 
been made to eradicate the leishmanial infections through 
vaccination and chemotherapy but progress on this front is 
still not very satisfactory. On the one hand vaccines 
currently tested against several forms of leishmaniasis has 
so far shown no promise to rely upon, while on the other hand 
the chemotherapeutic agents commonly used for combating the 
disease have a number of side effects including toxicity and 
immunosuppression. In view of the rather gloomy future, the 
only alternative is that the search for a new candidate 
vaccine(s) must continue. 
Present research represents one such step in that 
direction, where a preliminary effort has been made to 
search/identify some candidate vaccine(s) against visceral 
leishmaniasis. 
The experimental details of the proposed plan of study 
included work involving some of the following aspects: 
1. Maintenance of axenic in vitro, cultures of L. donovani 
(NICD: C II Strain). 
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2. I s o l a t i o n and p u r i f i c a t i o n o f d i f f e r e n t a n t i g e n i c 
f r a c t i o n s : w h o l e , s o l u b l e and p a r t i c u l a t e a n t i g e n 
i s o l a t e s . 
3. Biochemical c h a r a c t e r i z a t i o n of a n t i g e n i c f r a c t i o n s by 
e s t i m a t i n g t h e i r p r o t e i n , c a r b o h y d r a t e and DNA 
c o n c e n t r a t i o n s . Immunologic c h a r a c t e r i s a t i o n s were 
c a r r i e d out by means of IFA, IHA and ELISA. 
4 . Physico-chemical c h a r a c t e r i s a t i o n / i d e n t i f i c a t i o n s were 
c a r r i e d out by determin ing t h e i r molecular weights i n SDS 
PAGE. 
5. Vacc ina t ion s tud ies were c a r r i e d out by immunizing golden 
hamsters w i t h p u r i f i e d and cha rac te r i zed whole, s o l u b l e 
and p a r t i c u l a t e ant igens through i n t r a p e r i t o n e a l r o u t e s . 
6. Var ious ant igen f r a c t i o n s were immunopotent iated and then 
used f o r immunization of golden hamsters w i t h p u r i f i e d 
who le , s o l u b l e and p a r t i c u l a t e a n t i g e n f r a c t i o n s i n 
a s s o c i a t i o n w i t h BCG (2 x 10° B a c i l l e Ca lmet te -Guer in ) . 
7. Assessment of Humoral immune responses were c a r r i e d ou t 
by means of IHA and ELISA assay techn iques . 
8. I m m u n o g l o b u l i n l e v e l s were a s s a y e d i n immune and 
hyperimmune sera by using va r ious r a d i a l immunodi f fus ion 
techn iques . 
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9. The cell-mediated immune responses were also assayed in 
immunized and immunopotentiated animals by making use of 
in vivo DTH responsiveness or refractoriness. 
10. Protection studies in several groups of experimental 
animals were carried out by challenging the test animals 
with fatal does (1 x 10 promastigotes) of L. donovani 
(NICD: C II Strain). 
11. Detection of humoral immune responses through assessment 
of antibody titres by means of IHA and ELISA were 
subsequently carried out on post challenged animals. 
12. Post challenged animals were also tested for estimating 
their immunoglobulin levels. 
13. Cell mediated immune responses were again assayed in the 
above animals by employing DTH responsiveness and 
macrophage migration inhibition tests. 
14. The level of lysozomal enzymes (Acid Phosphatase) were 
estimated in the macrophages of immunized/ 
immunopotentiated animal groups. 
15. Therapeutic efficacy of the drug, Stibogluconate, was 
also tested by using smal1er/1arger doses of drugs in 
immunized/nonimmunized animal groups. 
M A T " E R I A L_S 
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1. Laboratory Culture 
Leishmania donovani parasites (NICD : C II strain) were 
cultured on brain heart infusion agar medium using HBSS as 
liquid pha»a. The above strain was initially obtained from 
the Biochemistry Division of the National Institute of 
Communicable Diseases (NICD), Delhi, India. 
2. Media and Buffer 
Dehydrated Brain Heart Infusion powder and Bacto Agar 
from Difco Laboratories, Detroit, Michigan, USA were used for 
culturing the parasites. The Nutrient Broth, Sabouraud's 
Dextrose Agar and Cooked Meat Medium were prepared according 
to the manufacturers instructions and sterilized in the 
laboratory. Hanks balanced salt solution (HBSS) and 0.1 M 
phosphate buffer saline (PBS) pH 7.2 were prepared in the 
laboratory according to the prescribed procedure. 
3. Animals 
H e a l t h y male g o l d e n h a m s t e r s (CDRI s t r a i n ) , each 
weighing around 80-100 gms, were purchased from the Animal 
House F a c i l i t y of the Centra l Drug Research I n s t i t u t e (CDRI) 
Lucknow, I n d i a . Hamsters were r o u t i n e l y used f o r in~vivo 
maintenance of Leishmania p a r a s i t e s and f o r i m m u n i z a t i o n 
purposes. 
46 
4 . Chemicals 
A n a l y t i c a l grade po tass ium phospha te (mono b a s i c ) , 
po tass ium phosphate ( d i b a s i c ) , sod ium c a r b o n a t e , sod ium 
c h l o r i d e , copper su lpha te , sodium potassium t a r t a r a t e , sodium 
h y d r o x i d e , sodium hydrogen p h o s p h a t e , d i s o d i u m h y d r o g e n 
p h o s p h a t e , p h o s p h o r i c a c i d , l i t h i u m s u l p h a t e , s o d i u m 
t u n g s t a t e , sodium molybdate, g lucose, magnesium c h l o r i d e , 
s u l p h u r i c ac id and formaldehyde were purchased from B.D.H. 
( I n d i a ) . Tannic ac id was purchased from W.J. Bush and Co. , 
Eng land , w h i l e Leishman s t a i n was pu rchased f r o m B . D . H . , 
England. Methanol was ob ta ined from Merck and Company, L t d . , 
and bovine serum albumin from SIGMA chemical company, U.S.A. 
A c e t i c a c i d ( g l a c i a l ) was pu rchased f r o m B .D .H . ( I n d i a ) . 
Tween 80 was o b t a i n e d f rom R i e d e l , Germany. H e p a r i n was 
purchased from Leo, Copenhagen, Denmark. 
The c h e m i c a l s used i n s o d i u m d o d e c y l s u l f a t e 
po lyacry lamide gel e l e c t r o p h o r e s i s (SDS-PAGE) were ob ta ined 
as f o l l o w s : 
A c r y l a m i d e , N ,N ' M e t h y l e n e b i s a c r y 1 amide , 2 -
Mercap toe thano l (LOBA-Chemie I n d o a u s t r a n a l C o . , Bombay -
I n d i a ) , Bromophenol b l u e , SDS-Laury l s u l f a t e , Ammonium 
pe rsu lpha te , N, N, N, N- te t ramethy le thy lene diamine (TMEDA) 
f rom B.D.H. , England. Urea f rom Merk Germany. B r i l l i a n t b lue 
(Coomassie b r i l l i a n t b lue ) f rom SIGMA,Chemical Company, 
U.S.A. 
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5. Anticoagulants 
Acid citrate dextrose (ACD), Sodium citrate, 3.8 
percent and Ethylene diamine tetraacetic acid (EDTA) were 
purchased from B.D.H. England. 
6. Preservatives and Antibiotics 
Sodium a z i d e was o b t a i n e d f r om R i e d e l , Germany. L i q u i d 
n i t r o g e n was made a v a i l a b l e t h r o u g h t h e c o u r t e s y o f 
D e p a r t m e n t o f P h y s i c s , F a c u l t y o f S c i e n c e , A l i g a h M u s l i m 
U n i v e r s i t y , A l i g a r h . 
7. Immunoadjuvants 
The BCG (Bacille Calmette-Guerin) was obtained from BCG 
Vaccine Laboratory, Madras, India. 
8. Conjugates and Substrates 
A n t i - h a m s t e r IgQ was p r e p a r e d i n t h e l a b o r a t o r y . 
A l k a l i n e p h o s p h a t a s e a n d p - n i t r o p h e n y 1 p h o s p h a t e w e r e 
pu rchased f r o m SIGMA Chemical Company, U.S.A. 
9 . C a p i l l a r i e s , D i a l y s i s T u b i n g and I n v n u n o d i f f u s i o n P l a t e s 
D i a l y s i s t u b i n g and c a p i 1 1 a r i e s w e r e p u r c h a s e d f r o m 
A r t h u r H. Thomas Company, U.S.A. I m m u n o d i f f u s i o n p l a t e s f o r 
IgG and IgM e s t i m a t i o n were pu rchased f r o m B e h r i n g , I n d i a . 
10. A n a e s t h e s i a 
A n a e s t h e t i c e t h e r I . F . was o b t a i n e d f r o m A l e m b i c 
Chemica l Works , Baroda, I n d i a . 
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11. Human Antisera 
Anti-L. donovani human sera were made available through 
the courtesy of Dr. A.B. Khan, Prof, of Pathology, Medical 
College, Darbhanga, Bihar.. 
12. Drug 
Drug (Stibogluconate) was purchased from Wellcome Pvt 
Ltd. (India). 
M E T H O D S 
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1. In vitro Cultivation of Parasite 
The promastigotes of L. donovani (NICD: CII strain) 
were maintained in Brain Heart Infusion Agar (DIFCO 
Laboratories, Detroit, Michigan, USA) using Hank's Balanced 
SaltSolution (HBSS) as the liquid phase according to the 
method of jalees et al, (1982). A one-tenth millilitre 
aliquot was inoculated into each tube containing 3 ml basic 
medium and 3 ml HBSS. The inoculated tubes were incubated at 
25° + 2°C in a BOD incubator (Calton, NSW, India) for 6 days. 
The organisms were routinely checked by obtaining a small 
sample from the culture tubes and examining the smear after 
staining with Leishman stain. 
1.1 Mass Cultivation of Parasite 
An 3 ml sample of 1.7 x 10 /ml healthy L. donovani 
promastigotes from a 6 day old culture was inoculated into 
100 ml culture medium in each flask containing 100 ml HBSS 
as an overlay. The inoculated tubes were incubated in a BOD 
incubator at 25° + 2°C for 6 days. The parasites were checked 
by making smears stained with Leishman's stain. 
1.2 Steri1ity Test 
Samples of Brain Heart Infusion Agar and HBSS were 
routinely inoculated in nutrient broth and cooked meat medium 
and incubated for a week at 37°C. The above media were 
checked daily for the presence of any contaminants. Subauroud 
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dextrose agar (SDA) medium was used for sterility testing of 
Leishmania cultures. 
1.3 Rate of Multiplication and Parasite Counts 
According to the method of Jalees et al, 1982, the rate 
of parasite multiplication was calculated by dividing the 
promastigote count per ml (on the day of examination) with 
the initial count, or with the previous day's count. The 
formula used for these calculations was as follows: 
No. of parasites incubated 
Count per 0 day = 
Volume of overlay/ media + Volume of 
inoculation 
Count after 6 days 
Time of multiplication = 
Count on 0 days 
A 10 fold dilution of the culture overlay, or the infected 
homogenate, was made in normal saline, while the motile 
nucleated Leishmania promastigotes were counted in a Neubauer 
Hemacytometer counting chamber. 
(a) Preparation of Leishman Stain 
Leishman stain solution was prepared by adding 150 mg 
of Leishman stain powder wrapped in a small piece of cotton 
in 100 ml methanol for 24 hr at 37°C. 
(b) Staining of Slide Smear 
Smears of the culture overlay, or the infected spleen 
homogenate, were dried and fixed in methanol for 4 min. The 
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stain solution was prepared by mixing equal volumes of 
Leishman stain and buffer saline (0.01 M, pH 7.2). The stain 
solution was layered on the films. The slides were left for 
30 min and then washed with PBS. The stained smears were 
examined under o i 1 - immersion in microscope (Carls Zeiss, 
Jena, West Germany). 
1.4 Measurement of pH 
A pH meter (Model L1-120, ELICO, Hyderabad, India) was 
used for all pH measurements. Sodium tetraborate (0.1 M, pH 
9.18) and Potassium Hydrogen Phosphate (0.05 M, pH 4.0) were 
used as standard buffer solutions to calibrate the pH meter. 
2. In vivo Maintanance of Parasite 
The hamsters were inoculated intraperitoneal1y with 
about 1 X 10 promastigotes of NICD-CII strain of L. donovani 
grown in Brain Heart Infusion Agar medium. After seven weeks, 
one hamster was killed by ether. The spleen was excised in 
sterile conditions and homogenated in 10 ml Tris (0.2M) -
Sucrose (0.25 M) buffer pH 7.8, using a Ten Broeck glass 
homogenizer. The homogenate was centrifuged at 150 x g for 10 
min and the pellet discarded. The supernatant was centrifuged 
at 1000 X g for 20 min and the resultant supernatant (first 
wash) discarded. The pellet was resuspended in 10 ml Tris-
sucrose buffer. The above procedure was repeated twice (Brun 
et al, 1976). After resuspending the washed amastigotes in a 
small amount of Tris-sucrose buffer, one millilitre of this 
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homogenate was inoculated into Brain Heart Infusion Agar 
medium. Several impression smears were air dried, fixed with 
methanol and stained with Leishman. 
3. Antigen Purification 
An t i gen p u r i f i c a t i o n was c a r r i e d o u t i n 6 day o l d 
c u l t u r e s o f L. donovani (NICD: C I I s t r a i n ) . F i r s t o f a l l 
repeated washing of promast igotes was made in PBS (pH 7.2) 
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to remove the extra material and were suspended at 1.2 x 10 
parasite/ ml in 100 mM Tris HCL and 1 mM EDTA (pH - 8) and 
were incubated at 4°C for 10 min. The parasites were then 
subjected to ultrasonication at 30 MHz for 1 min burst (x5) 
at 4°C, and examined microscopically to ensure complete 
parasite disruption. This preparation was treated as whole 
antigen. The whole antigen was then centrifuged at 105, 000 x 
g for 1 hr in order to get soluble and particulate antigen 
fraction. The method of Jalees et al (1981) was used with 
slight modification. 
4. Characterization of Antigen 
4.1 Protein Estimation 
The protein estimation in this study was done according 
to the method of Bradford (1976). 
(i) Preparation of standard solution 
10 mg of Bovine Serum Albumin was dissolved in 100 ml 
of .1 N NaOH. 
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(ii) Preparation of Coomassie Brilliant Blue (G-250 method 
for protein). 
(a) 10.0 mg Coomassie Brilliant Blue (G-250 was dissolved in 
5 ml 90* Ethyl alcohol. 
(b) 10 ml 85X Orthophosphoric acid was added in the above 
solution and kept for 3-4 hr, so that CBB G-250 was dissolved 
complete!y. 
(c) The volume was made upto 100 ml with DDW and the solution 
filtered in order to get a clear dye. 
(d) It was stored in a dark bottle at 4°C. 
Procedure: 
About 0.01 ml of antigen protein was added to 0.09 ml 
of DDW to make 1 ml volume. Then 2 ml of the prepared dye was 
added in the solution and read at 595 nm. Standard solution 
was used as control. 
4.2 Estimation of Carbohydrate 
Carbohydrates were estimated by using the method of 
Dubois et al (1956). Glucose solution was used as the 
standard. 
(a) Preparation of Standard Solution: 
10 mg of Glucose was dissolved in 100 ml of double 
disti1 led water. 
54 
(b) Preparation of Phenol Reagent: 
Phenol reagent was prepared by dissolving 8 gm of 
phenol in 100 ml of double distilled water. 
An 0.1 ml of antigen or glucose solution was brought 
upto 2 ml volume by the addition of double distilled water. 
Then 1 ml of freshly prepared phenol reagent was added. 
Later, 5 ml of concentrated Sulphuric Acid (95.5*) was added 
to the above mixture. The tubes were shaken vigorously and 
cooled at the room temperature. The colour intensity was read 
at a wave length of 490 nm. 
4.3 Estimatimation of DNA 
Estimation of DNA was carried out according to the 
method of Burton, 1956. 
(a) Diphenylamine Reagent 
This was prepared by the addition of 750 mg of 
diphenylamine to 50 ml of glacial acetic acid containing 0.75 
ml concentrated Sulphuric Acid. 
About 1 ml of antigen was mixed with 1 ml of 1N 
perchloric acid. The mixture was kept at 70°C in a water bath 
for 15 min. Then 0.1 ml of 5.43 mM acetaldehyde was added, 
after the addition of 2 ml of diphenylamine reagent. The 
tubes were left at room temperature for 16 hr. The colour 
intensity was read at 600 nm. 
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4.4 Molecular Weight Determination by SDS-PAGE 
Sodium dodecyl sulphate po1yacry1 amide gel 
electrophoresis (SDS - PAGE) was used for separation of 
protein subunits of L. donovani promastigote antigen, as also 
for determination of the molecular weights according to the 
slightly modified method of Laemmli (1970). The marker 
protein, used in this test were in the MR of : 29, 000, 45, 
000, 66,000, 97, 400, 116, 000, 205, 000 dalton as carbonic 
anhydrase, egg albumin, bovine albumin plasma, phosphorylase, 
galactosidase and myosin respectively, 
(a) Preparation of Reagents 
(I) Sample Buffer: 
This was prepared using the following concentrations 
NaHgPO^ 0.34 gm 
NagHPO^ 1.02 gm 
SDS-Lauryl Sulphate 1.00 gm 
2-Mercaptoethanol 1.00 gm 
Bromophenol Blue 0.015 gm 
Urea 36.00 gm 
The above constituents were dissolved and diluted to 100 ml 
with distilled water. The pH was adjusted at approximately 
7.0 at 25°C. The solution was stored in a refrigerator until 
used . 
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( I I ) Gel B u f f e r : 
The s o l u t i o n was p r e p a r e d by u s i n g t h e f o l l o w i n g 
c o n s t i t u e n t s : 
NaH2P0 6 .80 gm 
NagHPO^ 20 .45 gm 
SDS-Laury l S u l p h a t e 2 .00 gm 
The above c o n s t i t u e n t s were d i s s o l v e d and d i l u t e d t o 1 
l i t r e w i t h doub le d i s t i l l e d w a t e r . The pH was a d j u s t e d a t 
a p p r o x i m a t e l y 7 .0 ( 2 5 ° C ) . The s o l u t i o n was c o n s i d e r e d 
s u i t a b l e f o r use o n l y i n t h e absence o f any v i s i b l e m i c r o b i a l 
g r o w t h . 
( I I I ) Aery 1 amide Gel : 
Acrylamide 22.2 gm 
N,N' - Methylene 
bisacrylamide 0.6 gm 
The above constituents were dissolved and diluted to 
100 ml with double distilled water. The insoluble materials 
were removed by filtration. The solution was stored in a dark 
bottle in a refrigerator. 
(IV) N.N.N'N* - Tetramethylethylene diamine (TMEDA) 
(V) Ammonium Persulphate Solution: 
Approximately 100 mg ammonium persulphate was dissolved 
in 15 ml double distilled water. 
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(VI) Fixative Solution: 
This was prepared by combining the following: 
Methanol 400 ml 
Glacial Acetic Acid 70 ml 
Double Distilled water 530 ml 
(VII) Staining Reagent: 
This was prepared by dissolving 1.25 gm of brilliant 
blue (Coomassie Brilliant Blue) in 500 ml Reagent VI. The 
solution was stored in a tightly capped bottle at room 
temperature. 
(VIII) Destaining Reagent: 
It was prepared by combining: 
Methanol 50 ml 
Glacial Acetic Acid 75 ml 
The mixture was diluted to one litre with double 
disti1 led water. 
(b) Preparation of Sample: 
The antigens sample were adjusted at a concentration of 
about 1 mg protein/ml in the sample buffer (Reagent I). 
(c) Preparation of Electrophoresis Gels: 
Gel buffer (Reagent II) in a 15 ml quantity was mixed 
with 13.5 ml of acrylamide gel (Reagent III). The mixture was 
deaerated for one min with a water aspirator. About 1.5 ml of 
freshly prepared ammonium persulphate solution (Reagent V) 
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was deaerated for about 15 seconds and added to the above 
mixture. An 0.05 ml sample of TMEDA (Reagent IV) was also 
added. The resultant solution was mixed carefully to avoid 
the introduction of air bubbles. To each gel tube, 2 ml of 
this solution was carefully dispensed before the gel began to 
harden. A few drops of distilled water were layered on the 
top of the gel solution. 
(d) Electrophoresis: 
The gel b u f f e r (Reagent I I ) i n a 500 ml vo lume was 
d i l u t e d w i t h 1000'ml of d i s t i l l e d w a t e r . The w a t e r was 
decanted from the top of the g e l , wh i l e the b u f f e r s o l u t i o n 
was layered to top up the gel in each combed space, about 
10 u l sample was ove r l ayed on t he g e l . The t roughs o f 
e l e c t r o p h o r e s i s appara tus were f i l l e d w i t h d i l u t e d ge l 
b u f f e r , w h i l e a cons tan t c u r r e n t o f 4 mi 1 1 i amps /ge 1 was 
a p p l i e d f o r the f i r s t two h o u r s . The c u r r e n t was l a t e r 
i n c r e a s e d t o 8 mi 1 1 i a m p s / g e 1 u n t i l t h e m a r k e r dye 
(bromophenol b lue) was 1 cm from the anodic end of the g e l . 
The gels were removed from the g lass w a l l s . 
(e) Staining and Destaining: 
The gels were immersed in fixative solution (Reagent 
VI) for 10 hr (with several changes of fixative solution) and 
stained in the staining reagent (Reagent VII). The gels were 
left in the staining solution overnight. The destaining was 
carried out in the destaining solution (Reagent VIII) or by 
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diffusion against several changes of Reagent VI for 15 hr. 
The process of destaining was also carried out. 
The migration distance of tackling dye and the blue 
protien zone from the top of the gel was recorded. Finally 
gels were stored in the destaining solution (Reagent VIII). 
The relative mobility (RS) of a protein was determined 
by dividing its migration distance from the top of the gel to 
the centre of the protein band by the migration distance of 
the bromophenol blue tracking dye from the top of the gel. 
Distance of protein migration 
Distance of tracking dye migration 
The Rg values were plotted against the known molecular 
weights. The molecular weights of the unknown proteins were 
estimated with the help of calibration curve. 
4.5 Indirect Flourescent Antibody Test (IFA) 
(a) Preparation of Antigen: 
The promastigotes used for IFA test were harvested by 
centrifugation of overlay taken from 6 day old cultures at 
750g for 10 min (REMI - K24, India). The supernatant was 
discarded and the deposit was washed with PBS, pH 7.0 - 7.2 
five to six times till the supernatant became clear. The 
pallet was resuspended with PBS, then a drop of (3-5 jul ) was 
spotted on a clean slide. The slides were air dried, fixed in 
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acetone for 15 min. and again air dried. The slides were 
wrapped in tissue papers and packed in air tight containers 
in small batches. 
(b) Staining Procedure: 
Flourescein isothiocyanate conjugated with anti-human 
IgG ( Y "Chain specific) FITC (Wellcome Reagent) was used in 
this test. The test sera were inactivated at 56°C for 30 min. 
Two-fold serial dilutions were prepared with PBS. 
Antigen slides were removed from the freezer and air 
dried. The antigen spots were covered with drops of 
successive serum dilution and incubated in a moist chamber at 
37°C for 30 min. After incubation the slides were rinsed off 
with PBS in two or three changes of PBS for 10 min each. The 
smears were blotted dry and the optimum dilution of conjugate 
was applied to the antigen spot. The slides were incubated in 
moist chamber at 37°C for 30 min and later washed in PBS as 
above and dried with filter paper. The slides were then 
mounted with coverslips using buffered glycerol (90%). The 
edge of coverslips were sealed with finger nail varnish. Two 
control slides were prepared by placing a drop of PBS buffer 
on one slide and positive kala-azar antiserum on the other 
and stained as above. The stained slides were examined 
immediately using flourescent microscope (OLYMPUS, HB, 
Olympus Optical Co, Ltd., JAPAN) equipped with appropriate 
fi1ters. 
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4.6 Indirect Haemagglutination Test (IHA) 
Indirect Haemagglutination Test was carried out for 
checking the antigenicity of Leishmania whole antigen. The 
test was performed according to the method of Mathews et al, 
(1975). Microplates of U-shaped bottom (Cook U-plate, Cook 
Engineering Company, Alaxandria, Virginia, USA) were used for 
this test. Sheep red blood cells were washed four times in 
isotonic phosphate buffer saline, pH 7.2, by centrifugation 
for 10 min at 1500 rpm (REMI - K24, India). A 3% suspension 
of sheep RBC was prepared in isotonic PBS. The diluted RBC 
suspension was mixed with an equal volume of 1/20, 000 tannic 
acid and incubated at 4°C for 30 min with intermittent 
shaking. After incubation, the suspension was centrifuged at 
1200 rpm for 10 min and tanned sheep RBCs were washed three 
times with PBS containing 0.5X bovine albumin serum (BSA). 
The above was resuspended in PBS containing BSA to obtain a 
final concentration of 3% (v/v). The tanned sheep RBCs were 
sensitized with an equal volume of diluted antigen and 
incubated at 37°C for 30 min with intermittent shaking, so 
that the RBCs were uniformly coated with antigen. After 
incubation they were centrifuged to remove the uncoated 
antigen supernatant. The pellet was washed 3-4 times with PBS 
containing BSA. A ^.5% (v/v) antigen coated RBC suspension 
was made. The antisera samples were serially double diluted 
from 1:2 to 1: 32768. Each well in the plate received 25 ul 
of kala-azar serum alongwith an equal volume (25 ml) of 
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tanned and sensitized RBCs. The plates were rotated gently 
for five min, covered and sealed in a humid chamber and 
incubated at room temperature for 2 hr. The plates were kept 
over night at 4°C. The formation of mat like or carpet like 
patterns indicated a positive reaction. The highest dilution 
of the serum giving a positive reaction was recorded. 
4.7 Enzyme Linked Immunosorbant Assay (ELISA) 
This t e s t was performed accord ing t o the method of L in 
e t a l (1981) w i t h s l i g h t m o d i f i c a t i o n . A n t i - h a m s t e r IgG 
a l k a l i n e phosphatase c o n j u g a t e was used i n t h e t e s t . The 
p r e p a r a t i o n o f a n t i - h a m s t e r IgG a l k a l i n e p h o s p h a t a s e 
conjugate was done in t h i s way: 
( i ) I s o l a t i o n of Immunoglobulin g ( IgG) 
Serum was separated from the blood of hamsters. The IgG 
was p r e p a r e d a t 40$^ s a t u r a t e d ammonium s u l p h a t e . The 
p r e c i p i t a t e was washed t h r e e t i m e s a l t e r n a t i v e l y w i t h 
d i s t i l l e d water and ammonium su lpha te . The p r e c i p i t a t e was 
d i sso l ved i n normal s a l i n e and potassium phosphate b u f f e r , p H 
6 . 3 . The immunoglobu l in G was p u r i f i e d on DEAE c e l l u l o s e 
(Whatman DE 11 , U.K.) anion exchange accord ing to the method 
descr ibed by Sober e t a l (1956) . The p r o t e i n c o n c e n t r a t i o n 
was es t imated according to the method o f B rad fo rd , 1976. 
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(ii) Production of Anti-heimster IgG 
Three healthy rabbits were immunized with purified 
hamster IgG, intravanouely. Control animale war© inoculated 
with saline only. The immunization schedule was completed 
over a period of seven days in three inoculations. After the 
last immunizing dose, maximum antibody titres were detected 
by counterimmunoelectrophoresis at weekly intervals. 
Counterimmunoelectrophoresis was carried out according 
to the method of Bjerrum and B0g Hansen (1976) with slight 
modification. About 3 ml of 0.8 percent agarose gel was 
prepared in 0.025 M barbitol buffer, pH 8.6 containing 0.1 
percent sodium azide layered over glass slides of 25 mm x 75 
mm size. Agarose was allowed to solidify at room temperature 
and the slides were kept over night at 4°C. A set of 2 mm 
wide wells (5 mm apart) were punched in the agar. Cathodal 
wells were filled with antigen samples, while anti-hamster 
IgG antiserum samples were filled in the anadol wells. 
Electrophoresis was carried out for three hr at a constant 
current supply of 7 MA per slide at 150 volts. After 
electrophoresis, the slides were incubated at room 
temeprature for 4 to 5 hr in a humid chamber. After 
incubation the resolved precipitin bands were later recorded. 
The anti-hamster IgG was isolated on diethyl amino 
ethyl cellulose (DEAE) anion exchanger prepared according to 
the method of Sober et al (1956). About 2 mg of Anti-hamster 
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IgG in 0.1 ml of PBS was added to 5 mg of alkaline 
phosphatase and mixed at room temperature. The mixture was 
dialysed extensively against PBS at 4°C. Gluteraldehyde was 
added to give a concentration of 0.25«^  of the above mixture 
and incubated for 1 to 2 hr at room temperature. After 
incubation it was dialysed against PBS at 4°C, then against 
0.05 M Tris (hydroxymethy 1 amino ethane) buffer, pH 8.0, at 
4°C. To remove the insoluble materials, the solution was 
centrifuged at 5000 rpm for 10 min. The supernatant was 
diluted with Tris buffer containing fetal calf serum and 
0.02* sodium azide. The conjugate was stored in the dark at 
4°C until use. 
The ELISA test was performed in flat bottom microtitre 
plates (flat-bottomed; Cook Laboratory, Alexandria, Va, USA). 
The plates were coated with 20 ug antigen protein in 
carbonate buffer (0.05 M, pH 9.6) in each well, The plates 
were incubated at 37°C in a water bath for 6 hr, then at 4°C 
for the over night. After incubation, the plates were washed 
three times with phosphate buffer saline containing Tween -
20 (PBS/T, pH 7.4). An 0.2 ml of serially diluted positive 
kala-azar patient serum was added to each well and the plates 
were incubated for 2 hr at 37°C in a water bath. After 
incubation the plates were again washed three times. An 0.2 
ml of anti-hamster IgG alkaline phosphatase conjugate (1 x 
400 dilution with PBS/T) was added to each well. The plates 
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were incubated f o r 2 hr a t 37°C in a water ba th . The p l a t e s 
were washed th ree t imes w i t h PBS/T. An 0.2 ml subs t ra te (P-
n i t r o p h e n y 1 - p h o s p h a t e , 1 t a b l e t f o r each 5 ml o f 10 * 
d i e thano l amine b u f f e r ) was added t o each w e l l . A f t e r 30 min 
i n c u b a t i o n , the reac t i on was stopped by adding 0.05 ml of 3M 
NaOH. The co lour i n t e n s i t y was measured a f t e r 15-20 min a t 
400 nm wave length (Ser ies 700 M i c rop l a t e Reader, Cambridge 
Technology, I n c . , U .S .A . ) . 
5. Immunizaion S tud ies 
A l l i m m u n i z a t i o n e x p e r i m e n t s were c a r r i e d o u t i n 
hea l thy hamsters weighing between 80 - 100 gm. These s t u d i e s 
were done i n two s e p a r a t e e x p e r i m e n t s . I n t h e f i r s t 
e x p e r i m e n t t h e a n i m a l s i n t h e d i f f e r e n t b a t c h e s were 
a c c o r d i n g l y i n o c u l a t e d w i t h who le a n t i g e n , s o l u b l e and 
p a r t i c u l a t e a n t i g e n . In t he second s e t o f e x p e r i m e n t s t h e 
an ima ls were s i m i l a r l y i n o c u l a t e d w i t h d i f f e r e n t a n t i g e n 
p r e p a r a t i o n s such as who le , s o l u b l e and p a r t i c u l a t e i n 
c o m b i n a t i o n w i t h BCG as an a d j u v a n t . The i m m u n i z a t i o n 
schedule was as f o l l o w s : 
5.1 Experiment No.1 
Group I . Animals immunized w i t h whole an t igen 
Group I I . Animals immunized w i t h s o l u b l e an t igen 
Group I I I . Animals immunized w i t h p a r t i c u l a t e an t igen 
Group IV. Animals i nocu la ted w i t h normal s a l i n e 
Each hamster was i n t r a p e r i t o n e a l 1 y i n o n c u l a t e d w i t h 
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four injections, each containing 0.2 mg antigen protein given 
at four day intervals. The inoculum in each injection was 
made upto 0.5 ml with the addition of saline. The number of 
hamsters in each group was 10. The immunization schedule is 
shown in Table 1 . 
Eight animals randomly selected from each group were 
bled at day 30, 45 and 60 after the last immunizing 
injection. The sera obtained from these blood samples were 
used for the detection of the sequentially appearing anti-
leishmanial antibodies. 
5.2 Experiment No.2 
Group I. Animals immunized with whole antigen ->• BCG 
Group II. Animals immunized with soluble antigen + BCG 
Group III. Animals immunized with particulate antigen + BCG 
Group IV. Animals immunized with BCG only. 
Each hamster was given intraperitonea 1 1 y , a dose 
containing 0.2 mg antigen protein with 2 x 10 viable counts 
of BCG at four day intervals. A total of four injections were 
given for each animal. The inoculum in each injection was 
made upto 0.5 ml with the addition of saline. The number of 
hamsters in each group was 10. Eight animals randomly 
selected from each group were bled at day 30, 45 and 60 after 
the last immunizing injection. The immunization schedule is 
shown in Table 2. 
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5.3 Detection of Humoral Immune Response 
The sera samples obtained from different groups of 
immunizing animals were tested for the presence of anti L. 
donovani antibodies by means of IHA and ELISA tests. 
(a) Indirect Haemagglutination (IHA) Test 
Haemagglutination antibody titres were determined by 
the method of Mathews et al , 1975. A 3% suspension of sheep 
red blood cells (SRBC) was tanned with tannic acid (1:20, 
000) for 30 min at 4°C. The tanned cells were sensitized 
with antigen at 37°C for 30 min. The cells were added to two 
fold dilution of the serum. The highest dilution of the serum 
showing a positive reaction was recorded. 
(b) Enzyme Linked Immunosorbant Assay (ELISA) 
The ELISA test was performed according to the method 
described by Lin et al (1981) with slight modification as 
described before. 
(c) Estimation of Immunoglobulins 
The t o t a l c o n c e n t r a t i o n o f IgG and IgM l e v e l s were 
determined in the hyperimmune sera by s i n g l e r a d i a l immuno-
d i f f u s i o n technique (Mancini e t a l , 1965) us ing commercial 
p l a t e s coated w i t h a n t i s e r a t o human IgG and IgM (Behr ing , 
I n d i a ) . About 5 u l of the t e s t serum was added i n t h e 
app rop r i a te we l l s and the p l a t es were incubated f o r 72 hr 
f o r IgM and 48 hr f o r IgG. 
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5.4 Haematological Studies 
(a) Total Leukocyte Count (TLC) 
The blood samples from immunized animals were collected 
at day 30, 45 and 60 after the last immunizing antigen dose. 
Total leukocyte counts were made according to the method 
described by Dacie and Lewis (1970) for the detection of 
circulating peripheral leukocytes. The blood samples were 
collected in white blood cell counting pipettes upto 0.5 mark 
and diluted with Turk's fluid (2% glacial acetic acid in 
distilled water) to which methylene blue in small amount was 
also added. The leukocytes were counted in a hemacytometer. 
(b) Differential Leukocyte Count (DLC) 
Blood samples from immunized animals were collected at 
day 30, 45 and 60 after the last immunizing dose. The 
differential leukocyte counts were carried out as according 
to the method described by Dacie and Lewis (1970). 
5.5 Detection of Cell-mediated Immune (CMI) Response 
Cell mediated immune responses in all immunized 
animals were detected, in vivo, by means of delayed type 
hypersensitivity (DTH) reaction as according to the method 
described by Cook and Holbrook (1983). The DTH responsiveness 
was monitored by giving foot pad injections of washed 
promastigotes suspended in 0.5% phenol-saline (0.025 ml, 2.0 
X 10 ml). The thickness of the inoculated oot-pad was 
measured by using dial calipers ( IME England) at 24 hr 
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f o l l o w i n g i n j e c t i o n . The r e s u l t s were expressed as percent 
i n c r e a s e i n f o o t pad t h i c k n e s s when compared w i t h t h e 
u n i n j e c t e d f o o t . 
6. Protection studies 
All immunized animals vaccinated with samples of whole, 
particulate and soluble antigen (with or without BCG) were 
subsequently challenged with viable promastigotes (1 x 10 ). 
Each animal received an intraperitoneal challenge dose 
containing 1 ml of 1 X 10 promastigotes. The promastigotes 
used in this challenge study were harvested from the overlay 
of medium during log phase of the growth. The parasites 
harvested by centr i f ugati on at 1200 x g for 30 min were 
suspended in HBSS at a desired concentration. The 
promasti gotes used for the injection were passaged in vitro 
no more than 6 times. 
6.1 Detection of Humoral Immune Responses 
Four animals randomly selected from each group were 
bled through heart at day 15, 30, 45 and 60 after challenge. 
The collected serum samples were tested for the production of 
specific anti1eishmania 1 antibodies by indirect 
haemoagglutination (IHA) test and Enzyme Linked Immunosorbant 
Assay (ELISA) as described before. Also, specific 
immunoglobulins like IgG and IgM were estimated in the 
challenged animals as before. 
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6.2 Haematological Studies 
Total leukocyte counts and differential counts were 
made in the blood samples obtained at day 15, 30, 45 and 60 
after challenge. The above blood samples were collected in 
vials containing EDTA as an anticoagulant. These tests were 
carried out according to the method described by Dacie and 
Lewis (1970). 
6.3 Detection of Cell-mediated Immune Responses (CMI) 
The detection of CMI responses was carried out by 
employing skin hypersensitivity reaction. The footpad 
swelling in response to phenol suspension of promastigotes 
were used as an index of cellular immune responsiveness. This 
test was carried out according to the method described by 
Cook and Hoi brook (1983). 
6.4 Macrophage Migration Inhibition Test (MMIT) 
Following challenge, animals showing positive DTH 
reaction from each experimental group (with or without BCG) 
were injected intraperitonea11y with 10 ml of sterile 
paraffin oil. Two days later, animals were sacrificed and 
their peritoneal cavities washed with heparinized HBSS (100 
U/ml). The peritoneal fluid was collected into separating 
funnel and allowed to settle for 1 hr. The aquous phase was 
then separated from oil phase by centrifugation at 12000 rpm 
for 10 min. at 4°C using sterile disposable plastic 
centrifuged tubes. The supernatants were separated and the 
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cells were pooled and washed by HBSS for two times. After the 
last washing, the cells were suspended in RPMI-1640 (Gibco 
Laboratories, Grand Island, N.Y., 14072, U.S.A) containing 
Penicillin (100 units/ml) and Streptomycin (100 jug/ml) as 
antibiotics. The cells were counted in haemacytometer and the 
viability of cells was determined by 0.2 per cent trypan blue 
dye exclusion test. The viability of cells was not less than 
95%. The peritoneal exudate cells were adjusted at a 
concentration of 3 x 10 cells/ml. The cells were filled in 
75 Jul capillary tubes (1.1 internal diameter). The 
capillary tubes were sealed with sterile plasticin at one end 
and centrifuged at 800 rpm for 10 min. They were then cut at 
cell-fluid interface and placed in a Mackaness migaration 
chamber containing RPMI-1640 medium with 15 jug/ml antigen 
protein. Inactivated fetal calf serum (10X) and antibiotics 
(Penicillin and streptomycin) were also added to the filled 
chambers. The control chambers were without leishmania 
antigen. The cells were allowed to migrate for 48 hr at 37°C 
within an atmosphere of 536 CO2 in NBS CO2 incubator (New 
Brunswick Scientific, U.S.A., Model CO-20). The migration 
areas were projected, traced and measured by planimetry. Per 
cent migration inhibition was calculated as follows: % 
migration inhibition = 
Migration area with antigen 
X 100 
Migration area without antigen 
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6.5 Organ Impression Smears 
At day 15, 30, 45 and 60 after challenge, 4 animals 
from each group were killed in ether. The impression slides 
from spleen and liver were made by lighty dabbing the cut 
surface of the organ on absolute alcohol cleaned slides. The 
slides were air dried, fixed in absolute methanol and stained 
with leishman stain. The parasite burden in these tissues 
was determined by the method of Stauber (1966). About 1000 or 
500 cell nuclei were counted. The ratio of amastigotes per 
cell nuclei was calculated and multiplied first by the weight 
of the organ in milligrams for determining the parasite load 
in Leishman Donovan Unit (LDu). The above number was then 
multiplied by 2 x 10 to arrive at an approximate absolute 
number of parasite per organ. 
6.6 Assay of Acid Phosphatase 
The golden hamsters from each challenged group were 
injected intraperitoneal ly with 10 ml sterile paraffine oil. 
Peritoneal exudate cells (PEC) were collected according to 
the method described by David et al , 1964. Briefly the PEC 
after the last wash were suspended in PBS at a concentration 
7 ft 
of 1 x 10 -10 /ml and lysed by six cycles of freezing in 
liquid nitrogen and then thawing. The PEC lysate was 
centrifuged for 30 min at 12000 x g at 4°C (Beckman 
Preparative Ultracentrifuge, Model L8-55, USA), and the 
supernatant fluid removed and stored at -20°C. This soluble 
material was used for the assay of acid phosphatase. 
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Q u a n t i t a t i v e d e t e r m i n a t i o n o f a c i d phospha tase was done 
accord ing to the method of Beck e t a l (1968) . The s o l u b l e 
f r a c t i o n o f 2 x 10^ PEC (1 x 1 0 ' ^ u n i t s ) and 25 p i o f 
w 
param trophenyl phosphate disodium in acetate buffer pH 5 ^ a^s 
mixed and the final volume was made upto 750 p] . After 1 hr 
incubation at 37°C, the reaction was terminated by the 
addition of an equal volume of 2M ammonium hydroxide at pH 
10.7. The optical density of the nitrophenol product was 
measured at 420 nm. The activity was expressed in units, 
which released 1 mole of nitrophenol per minute per 1 x 10 
PEC. Assay was carried out in quadruplicate. 
6.7 Pathological Studies 
The vaccinated animal groups and control animal groups 
were sacrificed at day 15, 30, 45 and 60 after the challenge, 
for making gross observations of liver and spleen. These 
organs were excised and fixed in 10S6 formalin saline. The 
excised organs were sectioned and processed for detailed 
histopathological studies. The slides were stained with iron 
hematoxylin and eosin (M and E) and later examined 
microscopically. The slides from each animal group were 
photographed by Black and White film (OR WO Black and White 
negative film) using Nikon microscope. 
7. Drug Treatment 
S i n c e , c o m p l e t e p r o t e c t i o n i n t h i s s t u d y was n o t 
observed by vacc ina t i on s t u d i e s , t h e r e f o r e , a smal l dose of 
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the drug (Stibogluconate) was used in order to get a 100 per 
cent protection. The drug was prepared in 0.^% Tween 80 plus 
0.5X hydroxyethy1 cellulose (HEC-Tween) and administered 
twice through intramuscular route in vaccinated animals, 
following the establishment of infection in control animals. 
A dose of 2.5 mg/kg body weight was given to each animal. 
After three days the liver and spleen smears were made 
according to the method of Stauber et al, 1958. 
R E S U L X S 
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RESULTS 
1 . Axen ic C u l t i v a t i o n , in vitro, o f L. donovani ( N I C D r C I I 
s t r a i n ) 
A s a t i s f a c t o r y p a r a s i t e , L. donovani (NICD: C I I s t a i n ) , 
5 growth was ob ta i ned us ing BHMARB medium. About 5 .5 x 10 
c e l l s / m l were i n o c u l a t e d i n t h i s med ium. The l e v e l o f 
pa ras i taemia obta ined in a 168 hr c u l t u r e grown a t 25°C i s 
shown in (Table 3 ) . The p a r a s i t e s appeared hea l thy w i t h long 
f l a g e l l a ( F i g . 1 ) . 
1.2 Counting of parasite: Measurement of cell growth 
The growth of parasites, more or less, followed a 
similar pattern in mass cultures grown in 500 ml flask 
containing 100 ml medium (BHMARB) and 100 ml overlay (HBSS). 
After running a continuous culture for one month, a typical 
growth curve was obtained by plotting the number of parasites 
versus time (Fig,2). A continuous increase in the number of 
parasites was observed upto 168 hr. Subsequently, a gradual 
decrease in the number of parasites was noticed following 142 
and 216 hr of incubation. All parasite counts were made in 
Neubauer hemacytometer. 
2. Purification and partial characterization of parasite 
antigen 
2.1 The antigen preparation was made by the method of Obaid 
et al (1985) with slight modification. Three different 
q.1 Phctograoh showing Leishman stained L. 
doncvam (NICD:C II strain) promamstigotes 
from a 6 day old culture. 
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fractions as whole, soluble and particulate were obtained. 
The antigen preparation was free of whole parasites as seen 
under microscope (Zeiss Zena, West Germany) on an absolute 
alcohol cleaned slide. Microscopic examination confirmed 
complete lysis of parasites. 
2.2.a. Bio-chemical characterizations were made by estimating 
protein, carbohydrate and DNA concentrations of different 
antigen samples. The details of the result are given in 
Table 4. 
2.2.b. Molecular characterization of whole, particulate and 
soluble antigen was made by Electrophoresis using the method 
of Laemmli (1970) with slight modification. 
2.2.C. Immunological characterization for checking the 
antigenicity of different isolates was carried out by 
employing assay techniques such as IFA, IHA and ELISA. In IFA 
tests using Flourescein isothiocyanate conjugated with anti-
human IgG CY-chain specific) FITC (Wellcome Reagent) 
promastigotes were clearly seen under Flourescent microscope 
(Olympus, HB, Japan). The IHA test was performed according to 
the method of Mathews et al (1975). Here positive kala-azar 
serum was used against antigenic preparation (Table 5). ELISA 
was done according to the method of Lin et al (1981), ELISA 
titres obtained in different experiments are shown in Fig.3. 
Here ninteen bands were observed in whole antigen. One 
band having the molecular weight more than 94,000, two bands 
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in between 94,000 and 67,000, five bands in between 67,000 
and 43,000, five bands in between 43,000 and 30,000, five 
bands in between 30,000 and 20,160 and one diffused band in 
between 20,100 and 14,400 molecular weights range. In 
particulate antigen fourteen bands were observed. One band 
having the molecular weight of more than 94,000 and 67,000, 
four bands in between 67,000 and 43,000, one diffused band in 
between 43,000 and 30,000, five bands in between 30,000 and 
20,100 and one diffused band in between 20,100 and 14,400 
molecular weight range. In soluble antigen all the bands were 
very clear. Two bands in between 94,000 and 67,000, five 
bands in between 67,000 and 43,000, three bands in between 
43,000 and 30,000, three bands in between 30,000 and 20,100 
and four bands in between 20,100 and 14,400 molecular weight 
range were resolved (fig.^ and 5). 
3. Immunization was made with tested immunogenic antigens by 
i.p. route. In one set of experiment only antigen was given 
while in others antigen was given in association with BCG as 
an immunoadjuvant. 
3.1. Humoral Immune Response: 
Primarily humoral immune responses were detected in the 
immunized animals in both antigen and antigen plus BCG groups 
on day 30, 45 and 60. The antibody titres were higher in 
animals immunized with antigen only. Moreover, the use of 
IHA and ELISA techniques demonstrated that antibody titres 
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were higher on day 45 and after that they were decreased. The 
animals immunized with soluble antigen plus BCG showed 
highest antibody values both by IHA and ELISA (Table 
6,7,8,9). Specific Immunoglobulins like IgG and IgM were also 
detected by single radial immunodiffusion technique (Mancini 
et al, 1965) on day 45 post immunization. Here also IgG and 
IgM levels were higher in animals immunized with antigen plus 
BCG compared to animals immunized with antigen only. The 
level of IgG was higher compared to IgM in hyperimmune sera 
(Fig. 6 ) . IgG and IgM levels were highest in animals 
immunised with soluble antigen in association with BCG. 
3.2 Cellular Immune Responses 
Cell-mediated immune responses, in vivo, were detected 
by means of delayed type hypersensitivity (DTH) reaction. All 
the animal immunized with leishmania antigen in association 
with BCG were found negative for DTH responsiveness. Also 
the animals immunized with antigen only were found to be 
negative. 
3.3 Haematological studies 
3.3.a. Total Leukocyte Count (TLC) 
TLC was determined in animals immunized with leishmania 
antigen in association with BCG on days 30, 45 and 60, TLC 
values were higher in animals immunized with leishmania 
antigen in association with BCG on day 45 post immunization 
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compared to animals immunized with leishmania antigen only. 
The animals immunized with soluble antigen in association 
with BCG showed highest TLC values compared to other animal 
groups (Table 10, 11). 
3.3.b. Differential Leukocyte Count (DLC) 
DLC was also performed in all animal groups on day 30, 
45 and 60 post immunization. Details of the DLC values have 
been given in Table 12 and 13. 
4. Protection Studies 
A l l immun ized a n i m a l s v a c c i n a t e d w i t h l e i s h m a n i a 
a n t i g e n i n a s s o c i a t i o n w i t h BCG o r w i t h o u t BOG were 
cha l lenged by i . p . route w i t h a s tandard number of p a r a s i t e s 
which were able t o produce f a t a l i n f e c t i o n in hamsters (1x 
10 promast igotes) on day 45 post immunizat ion. Splenomegaly 
and heptomegaly was observed in c o n t r o l animals f o l l o w i n g 
cha l lenge (F ig 7 & 8) • 
4.1 Humoral Immune Responses 
Humoral immune responses were detected by IHA and ELISA 
to assay the antibody titres in the challenged animals on day 
30, 45 and 60. The antibody titres were considerably higher 
in animals immunized with leishmania antigen in association 
with BCG on day 45 post challenge. Furthermore, that animals 
immunized with soluble antigen in association with BCG were 
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found to be highest compared with other animals group (Table 
14, 15, 16, 17). The specific immunoglobulins like IgG and 
IgM were also detected in hyperimmune serum on day 45 post 
challenge by single radial immunodiffusion. Immunoglobulin 
levels were higher in animals immunized with leishmania 
antigen in association with BCG. The animals immunized with 
soluble antigen in association with BCG gave highest 
immunoglobulin levels. IgG titres were correspondingly higher 
compared to IgM levels in all the animal groups (Fig. 6 ). 
4.2 Cellular Immune Responses (CMI) 
4.2.a. DTH responsiveness 
The detection of CMI responsiveness was carried out in 
challenged animals on day 30, 45 and 60 by employing skin 
hypersensitivity reaction. The DTH responsiveness was 
positive in animals immunized with leishmania antigen in 
association with BCG. The animal groups immunized with 
soluble antigen in association with BCG were found to give 
DTH maximum reaction in tests. (Table 18). 
4.2,b. Macrophage Migration Inhibition Test (MMIT) 
Following challenge, the animals showing positive DTH 
responsiveness were tested again for CMI by MMIT. Macrophage 
migration inhibition was found to be highest in animals 
immunized with soluble antigen in association with BCG. The 
animals given BCG only also showed some slight inhibition in 
macrophage migration (Table 19). 
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5. Organ Impression Smears 
Organ impression smear studies from liver and spleen of 
challenged animals was done on days 15, 30, 45 and 60 post 
challenge. The animal groups immunized with antigen in 
association with BCG showed fewer parasites in liver as well 
as in spleen compared to animals immunized with antigen only. 
Moreover, the animals immunized with soluble antigen in 
association with BCG showed lowest parasite burden in liver 
and spleen (Fig, 9 and Table, 20, 21, 22, A 23). 
6. Assay o f Acid Phosphatase 
The es t ima t i on of ac id phosphatase was a lso taken as a 
parameter t o see the p a r a s i t e bu rden i n macrophages o f 
c h a l l e n g e d a n i m a l s . E s t i m a t i o n was done a t t h e t i m e when 
c o n t r o l animals patent i n f e c t i o n . Here g rea te r d e p l e t i o n of 
a c i d p h o s p h a t a s e was f o u n d i n a n i m a l s immun i zed w i t h 
le ishmania ant igen on ly , compared to animals immunized w i t h 
le ishmania ant igen in assoc i a t i on w i t h BCG. 
Lowest d e p l e t i o n o f a c i d phospha tase was found i n 
animals immunized w i th so lub le an t igen in a s s o c i a t i o n w i t h 
BCG ( F i g . l o ) . 
7. H i s t o p a t h o l o g i c a l Studies 
In the a n t i g e n - BCG g roup , t i s s u e r e a c t i o n s were 
minimal compared to other immunized groups ( F i g . 14, 16 & 
Whole Antigen +BCG 
Soluble Antigen fBCQ 
Particulate Antigen •BCG 
H BCG 
Whole Antigen 
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18). The spleen architecture in this batch was more or less 
unaltered, while the splenic tissue in control animals showed 
an accumulation of parasitized macrophages in the red pulp 
with hyperplasia of white pulp (Fig.12)- After 45 days of 
infection, the whole pulp showed parasitized macrophages, in 
addition to many foci of tissue necrosis. Although similar 
changes were observed in animals immunized with antigen only, 
but tissue necrosis was absent. The liver tissue reactions 
were less obvious in the antigen-BCG immunized groups (Fig. 
13, 15, & 17), The liver architecture was almost unaltered 
and the L.D. bodies were rarely seen in the macrophages after 
45 days of challenge. The liver of infected controls showed 
hyperplasia of Kuppfer cells and an accumulation of 
macrophages forming granulomatous foci (Fig.j2). The hepatic 
cells were atrophied and the normal architecture was 
disturbed. A large number of L.D. bodies were seen in 
hyperplastic macrophages. Animals immunized with parasite 
antigen alone were also seen to develop granulomatous foci; 
the liver architecture was also distorted. 
8. Drug Treatment 
Since, complete protection was not achieved by the 
present vaccination studies, therefore, a very small dose 
(2.5 mg/kg body weight) of the standard drug stibogluconate 
was used, intramuscularly. The use of this drug showed 
complete protection of priorly immunized animals with antigen 
ll L"'"?'' S'rct'on ^'''Z'Vf] 3. control hamst9r aftsr 
' • ' i 3 _ 1 1 o n n ; 5 5 n r i w i n n nUfT lSrOUS L . D . b o d l S S i n 
n a r - a j T - ' Z e d T i a c r o p h a n e s . T h e a r r o w 
i '~o^ce; te L . D . b o d i e s (H&E ••' 1 0 0 0 ) . 
12 S c ' e e f ^ s e c t i o n f r o m a c o n t r o l h a m s t e r 
a ^ t e - ' c t ' ^ a l ' l e n o e s h o w i n g a c c L i m u l a t i o n o f 
o a r a s i t " ! z e d m a c r o p h a n e s . T h e a r r o w s 
" i n d i c a t e t h e L . D . b o d i e s 'H&E y 1 0 0 0 ) . 
h 1 
F i g . 1 3 L i v e r s e c t i o n f r o m an a n i m a l i m m u n i z e d 
w i t h w h o l e a n t i g e n + BCQ s h o w i n g 
h y p e r p l a s i a o f K u p f f e r c e l l s (H&E x 4 0 0 ) . 
F i g . 1 4 S p l e e n s e c t i o n f r o m an a n i m a l i m m u n i z e d 
w i t h w h o l e a n t i g e n + BCG s h o w i n g 
p a r a s i t i z e d macrophages (H&E x 4 0 0 ) . 
I 
^ ^ ^ ^ . ^ . ^ t e ^ ^ B .^K. -MPT- - ^ 
Fig.15 Liver section from an animal immunized 
with particulate antigen + BCG showing 
hyperplas"ia of kupffer cells (H&E x 400). 
Fig.16 Spleen section from an animal immunized 
with particulate antigen + BCG showing 
white pulp invaded with moderate 
parasitized macrophages (H&E x 400). 
'v. _ 4u 
Fin.17 Liver section from an animal immunized 
w-jth soluble antigen + BCG showing 
accumulation of macroohages with no 
parasite (H&E x 400). 
Fig.18 Spleen section from an animal immunized 
with soluble antigen + BCG showing white 
pulp invaded with almost no parasitized 
macrophages (H&E x 400). 
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in association with BCG. The organ impression smears showed 
no parasites in the liver and spleen. Also, no hepatomegaly 
and splenomegaly was observed in such animal groups (Fig. 
19). 
F-ir). i9 P h o t o g r a b h s h o w i n g c o m p a r i s o n o f s p l e e n 
and l i v e r f r o m a n o r m a l and p r o t e c t e d 
an ima" ! s h o w i n g no s p l e n o m e g a l y and 
hepa tomega l y . 
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DISCUSSION 
The protozoan parasites of the genus Leishmania are the 
etiological agents of leishmaniasis which causes considerable 
morbidity and mortality in humans, the most serious of the 
many forms of leishmaniasis are the visceral types caused by 
the members of L. donovani complex. Visceral leishmaniasis is 
a debilitating, often fatal disease in man. The clinical 
sign may vary from one infected individual to another, 
according to the honst's ability to mount an effective immune 
defense response. For prophylactic purposes a few 
antileishmanial agents are commonly used in the medical 
practice but most of them are marked with relatively high 
toxicity, significant chemotherapeutic failures (TDR news, 
1990) and immunosuppressive effects (Adinolli and Bonventre, 
1990). M<3re currently, significant chemotherapeutic advanced 
and continued effort is under progress to develop a more 
suitable immunotherapeutic agent, because immunotherapy is a 
low-cast, low risk alternative to chemotherapy (Convit et al, 
1987). 
Numerous investigations have so far been carried out to 
determine the immune aspects of the disease. The increasing 
evidences indicate that CMI mechanisms play a major role 
while humoral immune mechanisms only marginally help in 
protection through acquired immunity to visceral 
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leishmaniasis (Preston and Durflonde 1976b; Poulter 1980; Reed 
1981). Since leishmanial infections are broadly related to 
depressison of eel 1-mediated immunity, and it has long been 
clear that vaccines need to induce protective T-cell mediated 
immunity against the protozoan, therefore the aim is to 
prevent multiplication of the parasite within macrophages. 
Earlier work has already demonstrated that cytokines released 
by antigen-specific 004"*" T-cells enhance the anti leishmanial 
activity of macrophages. Both oxygen-dependent and oxygen-
independent 1 eishmanicidal agents have been implicated 
(Playfair et al,1990). Although, the leishmanicidal actions 
by different means have been fairly elucidated (Nacy et al 
1981; Ridel et al 1987), but no vaccine against any form of 
leishmaniasis has been shown conclusively to be effective 
(Report of WHO Expert Committee, 1990). 
Vaccination experiments in laboratory animals have been 
carried out using killed or attenuated parasites in 
combination with several immunoadjuvants. But complete 
protection of vaccinated animals has hardly been ever 
achieved. The use of different types of antigen preparations 
in such vaccination experiment was largely responsible for 
obtaining somewhat varying results (Holbrook and Cook 1983; 
Scott et al 199o/). Attempts have also been made towards 
immune enhancement of the host with the help'of adjuvants for 
eliciting a more potent protective immunity. Killed 
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leishmania promastigotes together with live BCG were used for 
immunization of patients (Convit et al., 1987) where 94% 
protection was achieved. Earlier work of this nature in our 
laboratory has shown that whole, particulate and subcellular 
fractions of leishmania antigen in combination with glucan 
[(S-1,3) polyglucose, a derivative of inner cell wall of 
Sacchromyces cerevisae], can induce protective immunity in 
golden hamsters (Obaid et al., 1989). 
The present investigation describes the activity of 
Bacille Calmette-Guer i n (BCG) as an i mmunoad j uvant for 
immunizing golden hamsters with whole, particulate and 
soluble fractions of L. donovani antigens. The antigenic 
stimulation provided to the animals with the help of BCG was 
assayed and characterized in detail. First of all, L. 
donovani whole antigen was prepared from laboratory cultures 
in Brain Heart Infusion Agar medium using HBSS as the liquid 
phase. The whole antigen was further fractionated into 
soluble and particulate antigen fractions. The antigens 
before immunization were partially characterized and 
immunizations were carried out either by the three antigen 
fractions only, or in combination with BCG in golden 
hamsters. The degree of protection afforded by these vaccine 
candidate antigens was assayed by estimating the humoral and 
CMI responses following immunization. 
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The induction of protective immunity, or the extent of 
immune protection acheieved was studied by challenging the 
immunized animals with viable L. donovani promastigotes (1x 
10 ). The protection criterion was largely based on lowered 
organ parasite counts, rising antibody titres in ELISA and 
IHA tests, enhanced IgG and IgM levels in hyperimmune sera 
and, the appearance of delayed hypersensitivity response to 
leishmania antigen and increased macrophage migration 
inhibition in vaccinated animals. Haemato1ogical and 
pathological parameters were also taken into consideration 
for estimating the degree of protection. Also, the level of 
acid phosphatase was assayed in vaccinated animals in order 
to see the extent of protection. 
Since complete protection was not achieved in this 
study, therefore, a small dose of Stibogluconate was used 
intramuscularly to render the vaccinated animals completely 
protected. The protection studies were largely based on 
estimating the parasite burden in the liver and spleen by 
organ impression smears. 
The parasites from different Leishmania species are 
almost indistinguishable morphologically, but the results of 
molecular and immunological analysis such as electrophoretic 
patterns of isoenzymes (Miles et al , 1980), buoyant density 
of K-DNA and nuclear DNA (Shaw, 1982), serology of excreted 
factors (Schnur et al , 1972), reactions using monoclonal 
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antibodies (McMahon-Pratt et al, 1982) and antigen 
preparations have helped to solve the different intricate 
problems. Since purification of parasite antigen needs large 
number of parasites free from contaminants therefore a large 
number of media has been devised for the cultivation of L. 
donovanai, in vitro. However, the majority of such media are 
not entirely satisfactory for large scale cultivation of 
parasites, especially for the purpose of antigen isolation 
and for carrying out a large number of other immunological 
studies. 
In this study Brain Heart Infusion Agar medium using 
Hank's Balanced Salt Solution (HESS) as a liquid phase, was 
used for large scale cultivation of L. donovai. This medium 
was found to give maximum growth in our cultures. This medium 
was also supplemented with citrated rabbit blood. The Brain 
Heart Infusion Agar Medium supplemented with citrated rabbit 
blood is still used by a number of workers (Jalees et al , 
1979) for in vitro cultivation of this parasite. It has been 
claimed to be very suitable for antigen preparation. The HBSS 
used in this medium as overlay contained 0.25 percent glucose 
instead of 0.1 per cent. This overlay was proved to be more 
superior and better than Locke's solution. The initial 
inoculum in our study was 5.5 x 10^ cells/ml at a 0 hr 
reading and maximum growth was obtained at 168 hr reading 
where the rate of multiplication at 168 hr reading was found 
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to be 6 X 10 /hr. Here the number of parasites at 168 hr 
q 
reading was 1.0 x 10 cells/ml 
During the course of earlier studies in our laboratory 
by Obaid et al (1985) brain heart infusion agar medium was 
supplemented with 50% egg homogenate for in vitro cultivation 
of L. donovani in which maximum growth was obtained in 
cultures. The starting inoculum was 1.7 x 106" eel Is/ml, that 
Q 
gave a yield at 1.2 x 10 cells/ml at 168 hr reading. Our 
results using brain heart infusion agar medium supplemented 
with citrated rabbit blood are similar to that of Obaid et 
al , 1985. Ray and Ghosh (1980) have used a liquid culture 
medium (LDLC-II) for bulk cultivation of L. donovani 
promastigotes. The maximum growth in this medium was obtained 
between 10-13 days after which the parasite count declined. 
Whole antigen preparation was made from 6th day old 
cultures following repeated washing in PBS (pH - 7.2) to 
remove the extra material and the organisms were resuspended 
at 1.2 X 10^ parasite/ml in 100 mM Tris HCL and ImM EDTA 
(pH.B) which were incubated at 4°C for 10 min. The parasites 
were then subjected to ul trasoni cati on at 30 MHz for 1 min 
burst (X5) at 4°C, and viewed microscopically to ensure 
complete parasite disruption. The parasite suspension was 
then centrifuged at 105,000 X g for 1 hr in order to get 
soluble and particulate antigen fraction. The above 
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operations were carried out according to the method of 
Jalees et al (1981) with slight modification. 
Cook and Hoi brook (1983) have used another method for 
extraction of parasite antigen. They used alternate freezing 
and thawing for obtaining soluble and particulate antigen 
fractions. The preparation was further fractionated by 
sonication, followed by centrifugation at 11,000 x g for 20 
min. Leon et at (1986) have used yet another method for 
antigen purification. Cells obtained from bulk growth were 
harvested on the seventh day, washed 6 time with 0.15 mol/1 
phosphate-buffered saline at pH 7.2, and disrupted by 
sonication at 95 W, five times (3 min each). This sonicated 
material was ultracentrigued at 100,000 x g for 30 min and 
the supernatant was filtered through an 0.2 um millipore 
membrane. In order to minimize proteolytic degradation, all 
the procedures were carried out at 4*^ C. 
For immunization purposes, Scott et al (1987) have 
used the following procedure for obtaining soluble antigen 
preparation. The parasites were grown in medium 199 with 20X 
fetal bovine serum, 2 mM glutamine, 100 u/ml penicillin G-
potassium, 100 ug/ml streptomycin sulphate and 25 mM HEPES 
at 27°C. Log growth phase promastigotes were used for antigen 
preparation, because in preliminary experiments these 
promastigotes proved better for immunizing the animals than 
stationary growth phase organism. Promastigotes were 
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radiation-attenuated by exposure to 50,000 rad-irradiation 
13 7 
f r o m a c e s i u m ( Cs ) s o u r c e , o r w e r e h e a t k i l l e d by 
i n o c u l a t i o n a t 56*^0 f o r 1 h r . To p r e p a r e s o l u b l e l e i s h m a n i a 
a n t i g e n , p r o m a s t i g o t e s w e r e w a s h e d f o u r t i m e s i n c o l d 
q 
phosphate buffered saline and were resuspended at 1.2 x 10 
parasite/ml in 100 mM Tris-HCL 1 mM EDTA (pH-8) with 50 jjg/ml 
leupeptin, 50 jug/ml ^-2-macroglobulin, and 1.6 mM 
phenylmethyIsulfonyl fluoride and were incubated at 4°C for 
10 min. The parasites were then subjected to sonication at 
4*^C with 2-20 sec blasts and were viewed microscopically to 
ensure that all the parasites had been disrupted. The 
parasite suspensions were then centrifuged at 27000 x g for 
20 min, and the supernatant was collected and recentrifuged 
at 100,000 X g for 4 hr. The supernatant was then harvested 
and dialyzed against PBS, and was sterilized by passage 
through a 0.22 .urn filter. 
Chemical characterization of parasite antigen showed 
that protein-carbohydrate ratio in the whole, particulate and 
soluble antigen was 2.14:1, 2.73:1 and 10.2:1, respectively. 
The results clearly suggest that the various antigenic 
fractions of L. donovani antigen are both of protein and 
carbohydrate nature. A small amount of DNA was also found in 
these antigenic preparations. Some workers in this area 
suggested a protein-polysaccharidic nature of L. donovani 
promastigote antigen (Ghosh and Roy^ 1983). Moreover, many 
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o ther workers have prepared a carbohydrate r i c h f a c t o r which 
r e a c t e d s t r o n g l y w i t h homologous r a b b i t a n t i s e r u m r a i s e d 
a g a i n s t p r o m a s t i g o t e s . These c o m p o n e n t s a l t e r n a t i v e l y 
l a b e l l e d as e x c r e t i o n f a c t o r , exometabo l i t e , or a n t i g e n i c a l 1 y 
a c t i v e g l y c o p r o t e i n s have been used i n s e r o t y p i n g o f 
le ishmania s t r a i n s (Schnur e t a l , 1972). 
Whole a n t i g e n p r e p a r a t i o n i n SDS PAGE r e s o l v e d i n t o 
n ineteen bands. One band having the molecular weight of more 
than 94,000, two bands i n between 94,000 and 67,000, f i v e 
bands i n between 67,000 and 43 ,000 f i v e bands i n between 
43,000 and 30,000, f i v e bands in between 30,000 and 20,100 
and one d i f f u s e d band in between 20,100 and 14,400 da l t ons 
were observed. In p a r t i c u l a t e an t igen f ou r teen bands were 
observed. One band having the molecu lar weight of more than 
94,000, two bands in between 94,000 and 67,000, f ou r bands in 
between 67,000 and 43 ,000 , one d i f f u s e d band i n be tween 
43,000 and 30,000, f i v e bands i n between 30,000 and 20,100 
and one d i f f u s e d band i n between 20,100 and 14,400 d a l t o n s 
were d e t e c t e d . In s o l u b l e a n t i g e n s e v e n t e e n bands were 
observed: two cands in between 94,000 and 67,000, f i v e band 
in between 67,000 and 43,000, th ree bands in between 30,000 
and 20,100 and f o u r bands i n between 20 ,100 and 14 ,400 
d a l t o n s . Ramasamy e t a l (1981) have shown the presence o f one 
band of 53,000 da l ton on the ou te r sur face membrane o f L. 
donovani p romast igotes . Four l a b e l l e d p r o t e i n s w i t h molecu lar 
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weight values of 65,000, 60,000, 50,000 and 26,000 were 
detected in both L. donovani and L. chagasi extracts (Lamesre 
et a1, 1985). 
Defnitive diagnosis of visceral leishmaniasis depends 
on the microscopic demonstration of Leishman-Donovan (LD) 
bodies in the bone marrow/spleen biopsy or by culture of 
aspirated fluid. But the patients where the demonstration of 
LD bodies is not possible, the diagnosis is oonly presumptive 
(Srivastava, 1989). With the development of sensitive and 
specific antigens a number of tests have now become available 
for diagnosis of the disease. They include indirect 
haemagg1utination (IHA) test (Bray and Lainson, 1967), 
indirect flourescent antibody (IFA) test (Quilci et al, 1968; 
Shaw and Volter, 1964) and enzyme linked immunosorbant assay 
(ELISA), (Hommel et al, 1978). Among the different techniques 
which have been used for diagnosis of kala-azar, micro ELISA 
was found to be more sensitive than other tests like IFA, 
IHA, and ELISA (Srivastava, 1989). Other serological tests 
including immunofluorescence, were also used by numerous 
workers for the detection of specific antibodies to L. 
donovani. These tests are passive haemagg1utination , gel 
precipitation and complement fixation (Kagan, 1975; Pappas et 
al , 1985). ELISA was found more practical than 
indirect fluorescence antibody test in large scale 
seroepedimiolgical surveys for kala-azar (Srivastava 1989, 
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Choughdry et a1., 1990; Gupta et al., 1993). The first 
application of this technique (ELISA) in the detection of 
leishmania antibodies by Homme! (1976) and Voller et al 
(1976) had shown promising results. Antibody to L. donovani 
was also detected with IHA test in patients with kala-azar 
and post kala-azar dermal leishmaniasis in India (Mukherjee 
et al , 1968; Sen Gupta 1968). More recently Evans et al 
(1990) have also used IFA and ELISA in Brazilian Dogs 
infected with L. donovani chagaz i. Of 405 dogs; Q% were 
positive by IFA obtained from blood collected by drying onto 
filter paper followed by elution, 17^ were positive by IFA 
against appropriate sera, while 385^  were positive in ELISA 
using the same sera. The ELISA recognized all the dogs with 
proven infection but IFA detected 10 to 12 only. In this 
study IFA tests were also performed in order to see the 
antibody titres. Pearson and Roberts (1990) have also used 
IFA technique to demonstrate immunoglobulin bound to the 
surface of hamster spleen infected with amastigotes of 
L . dona vani. 
Earlier workers in our laboratory have used ELISA and 
IHA to see the antibody titres in the golden hamsters 
immunized with leishmania antigen in association with glucan 
(Obaid et al , 1989). ELISA and IHA tests were successfully 
employed in this study where higher antibody titres were 
found in the animals immunized with parasite antigen only. 
But, animals immunized with whole antigen plus BCG showed a 
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h igher ant ibody t i t r e s than those ob ta ined w i t h i n d i v i d u a l 
a n t i g e n f r a c t i o n s . Next i n t h e o r d e r , were t h e a n t i b o d y 
t i t r e s o b t a i n e d f rom an imals wh i ch a re g i v e n p a r t i c u l a t e 
an t igen f r a c t i o n in assoc i a t i on w i t h BCG and s o l u b l e an t i gen 
f r a c t i o n p lus BCG. 
The appearance of eel 1-mediated immune responses i n 
the immunized an imals was d e t e c t e d in vivo, by means o f 
de layed t ype h y p e r s e n s i t i v i t y (DTH) r e s p o n s i v e n e s s and 
macrophage m ig ra t i on i n h i b i t i o n t e s t (MMIT). Th is t e s t has 
been w ide ly used in s tud ies on the epidemiology o f ka la -aza r 
i n Kenya ( M a n s o n - B a h r 1961) and o f m u c o c u t a n e o u s 
l e i s h m a n i a s i s i n South Amer ican c o u n t r i e s (Pessoa and 
P e r e i r e B a r r e t t o 1948). Costa e t a l ( 1988 ) have used DTH 
responsiveness to le ishmania an t igen in t h e i r v a c c i n a t i o n 
s t u d i e s of mice as one of the parameters t o see the ex ten t o f 
p r o t e c t i o n . The le i shman ian t e s t was f o u n d s l i g h t l y more 
s p e c i f i c f o r l e i s h m a n i a s i s , a l t h o u g h i t i s n o t s p e c i e s 
s p e c i f i c (Manson-Bahr 1961). However, i n cases o f cutaneous 
l e i shman ias i s a very s t rong DTH r e a c t i o n t o le ishmanin was 
o b s e r v e d 14 y e a r s a f t e r l i v i n g i n a n o n - e n d e m i c a r e a 
(Modabber 1990). Th is s t r o n g l y s u g g e s t s t h a t a n t i g e n o r 
p a r a s i t e s pe rs i s t ed f o r a very long t ime a f t e r recovery f rom 
the i n f e c t i o n . 
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In the present investigation, the DTH, as measured by 
footpad swelling in response to animal challenge by phenol 
suspensions of promastigotes, was negative in all the 
hamsters immunized with leishmania antigen with or without 
BCG. The skin testing for CMI was carried out on day 30, 45 
and 60 post immunization. Our results showed that cell-
mediated immune response developed 30 days after challenge 
with viable L. donovani promastigotes. These tests were 
positive only in animals immunized with leishmania antigen in 
association with BCG. But the animals, receiving antigen only 
were not able to generate such delayed type reactions. In 
order of magnitude, the DTH response was higher in animals 
receiving soluble antigen in association with BCG; followed 
by animals receiving particulate antigen with BCG and, those 
given whole antigen with BCG. 
Promastigotes of L. donovani are immobilized and killed 
by normal human serum, whereas the amastigotes formed after 
multiplication in macrophages are not affected. The killing 
has been shown to be due to IgG and IgM binding followed by 
activation of the classical complement pathway (Pearson and 
Steigbigel 1980). Considerable increase in serum "y-globulins 
(primarily IgG) are reported in human visceral leishmaniasis 
(Manson-Bahr 1971; Bray 1972; Ghose et al , 1980). The 
increase in "y-globulin levels in squirrel monkeys challenged 
with L. donovani was due primarily to IgG and to a lesser 
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ex ten t t o IgM. The f a c t o r s c o n t r i b u t i n g t o the increase i n 
> C - g l o b u l i n l e v e l s in v i s c e r a l l e i shman ias i s are not c l e a r l y 
k n o w n , b u t t h e i n c r e a s e i s t h o u g h t t o r e s u l t f r o m a 
p o l y c l o n a l B-ce l l a c t i v a t i o n of immunoglobul in s e c r e t i n g 
c e l l s (Campos-Neto and Bunn-Morenso 1982; Be lehun e t a l , 
1980), lead ing to increased syn thes i s of IgG (Ghose e t a l , 
1980). 
In our s tudy the an ima ls immunized w i t h a n t i g e n i n 
a s s o c i a t i o n w i t h BCG showed h i g h e r i m m u n o g l o b u l i n l e v e l s 
compared t o animals immunized w i t h an t igen o n l y . Among the 
antigen-BCG group the l eve l of immunoglobul in was h ighes t i n 
the animals immunized w i t h s o l u b l e an t igen i n a s s o c i a t i o n 
w i t h BCG. The leve l of IgG was every t ime h igher i n each 
g r o u p compared t o IgM l e v e l . The a n i m a l s w h i c h were 
cha l lenged a f t e r immunization w i t h 1 x 10 promast igotes a l so 
showed h i g h e r IgG and IgM l e v e l s compared t o immunized 
g r o u p s . A g a i n t h e a n i m a l s i m m u n i z e d w i t h a n t i g e n i n 
a s s o c i a t i o n w i th BCG on cha l lenge showed h igher IgG and IgM 
l e v e l compared t o a n i m a l s i m m u n i z e d w i t h a n t i g e n i n 
a s s o c i a t i o n w i t h BCG. The s o l u b l e an t i gen -BCG immunized 
group on cha l lenge showed h igher IgG and IgM l e v e l s compared 
to a l l o ther groups. Furthermore, the animals immunized w i t h 
whole and p a r t i c u l a t e a n t i g e n showed l o w e s t IgG and IgM 
l e v e l s compared to a l l the groups. The animals immunized w i t h 
whole an t igen and p a r t i c u l a t e an t igen i n a s s o c i a t i o n w i t h 
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BCG showed somewhat higher levels of IgG and IgM compared to 
animals immunized with antigen only. Our studies are similar 
to that of Dennis et al (1986) who carried out experiments on 
monkeys. They infected monkeys shown IgG levels which were 
higher than IgM levels. 
Leishmania infections are broadly related to depression 
of cell-mediated immunity, and it has long been clear that 
vaccines need to induce protective T-cell mediated immunity 
against protozoa. The aim is to prevent multiplication of the 
parasite within macrophages. More recently, Sypek and Wyler 
(1990) have demonstrated using lymph node lymphocytes from L. 
major infected mice and cloned T-cell hybridoma that 
macrophages can be in vitro activated to exert 
antileishmanial defense. The clone 1D5, produced lymphokines 
(including gaiT.ma interferon) that induced these affects. 
Production of macrophage activating lymphokines and the 
protective effect of 1D5 were enhanced by the addition of 
Cyclosporin A to the cultures. In our studies on CMI, the 
macrophage migration inhibition test (MMIT) was maximally 
positive in animals receiving soluble antigen in association 
with BCG. Animals which received particulate antigen with 
BCG, and those which received whole antigen with BCG, also 
showed higher values. Animals which were given BCG alone were 
almost negative in these tests. The results from skin testing 
and MMIT experiments were in agreement with each other. Our 
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results are in agreement with other workers who have used 
leishmania antigen in association with glucan as an adjuvant 
for experimental immunization (Cook and Holbrook 1983; Obaid 
et al., 1989). 
The mechanism whereby leishmania amastigotes survive in 
mononuclear phagocytes in the presence of lysosomal enzymes 
is not known. Alexander and Vickerman (1975) suggested that 
the inhibition of host lysosomal enzymes by amastigotes might 
account for their survival in the macrophage. The studies of 
El-On et al (1980) supports this hypothesis, suggesting that 
this inhibition might be mediated by excreted factors. 
In our study, a depletion in acid phosphatase activity 
was observed in macrophages infected with L. donovani. The 
animal groups immunized with antigen only showed more 
depletion in acid phosphatase activity when challenged with 
L. donovani promastigotes compared to animal groups which 
received antigen in association with BCG. The animals which 
were immunized with antigen in association with BCG showed 
less depletion in acid phosphatase activity when challenged 
with L. donovani promastigotes. The animals immunized with 
soluble antigen in association with BCG showed lowest 
depletion in acid phosphatase activity when challenged with 
L. donovani promastigotes. Moreover, animals immunized with 
particulate antigen and whole antigen in association with BCG 
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when challenged showed more acid phosphatase depletion 
compared with soluble antigen-BCG immunized group. 
The clinical sign may vary from one infected individual 
to another, according to the host's ability to mount an 
effective immune defense. Increasing evidences indicate that 
CMI mechanisms play a major role and humoral immune 
mechanisms a minor role in acquired immunity to visceral 
leishmaniasis (Preston and Dumonde 1976; Poulter 1980; Reed 
1981). In the active stage of visceral leishmaniasis, the CMI 
is absent, or not prominent, therefore an increasing number 
of patients with acquired immunodeficiency syndrome (AIDS) or 
other forms of immune defeciency are being reported to suffer 
recrudescent leishmaniasis (Bodaro et al , 1986; Franco-
Vicario et al, 1987; Mulliez et al, 1987). This may be one of 
the reasons why hypersensitivity reactions and leishmania 
skin tests become positive only after 6-8 weeks of treatment. 
Excellent studies in rodents suggest that T-cells (Skov 
and Twohy 1974), natural killer cells (Kirkpatrik and Fareell 
1982) and soluble mediators (Murray et al, 1982) are possible 
mechanisms responsible for acquired resistance in visceral 
leishmaniasis. However, antibodies may also play a role in 
resistance, since humans completely cured of visceral 
leishmaniasis develop a strong transient Arthus reaction at 
the site of reinoculation with L. donovani, and parasites 
are not recovered at the site of the challenge inoculum 
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(Manson-Bahr 1961). In the present study, challenged animals 
which received parasite antigens in association with BCG 
showed higher antibody titres compared to those given 
parasite antigen alone. Moreover, the antibody titres in 
animals immunized with soluble antigen in association with 
BCG were highest compared to animals immunized with 
particulate antigen and whole antigen in association with 
BCG. 
Following immunization, higher values in total 
leukocyte count (TIC) were observed in animals immunized with 
parasite antigen in association with BCG. The animals which 
were given only parasite antigen showed slight changes in TLC 
compared to control animals. Animals which received only BCG 
also showed an increase in TLC values. In addition, the 
percentage of polymorphonuclear leukocytes was higher in the 
antigen-BCG groups than the animal groups immunized with 
antigen alone. The TLC values were highest in animals 
immunized with antigen in association with BCG compared to 
animals immunized with particulate and whole antigen in 
association with BCG. It has been shown that some decline 
occurs in the parasite burden of spleen and liver of the 
BALB/c mice inoculated with BCG (Smrkovski and Lainson 1977). 
Moreover, complement fixing antibodies produced by 
visceral leishmaniasis patients are best demonstrated with 
the use of Mycobacterium antigens (Lainson and Bray 1966). 
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Even though these antibodies have no detectable role in 
immunity against the disease, the use of Mycobacter i urn 
antigen in the complement fixation test for visceral 
leishmaniasis indicates a specific cross reactivity between 
members of protozoan genus, Lei shmani a, and the genus 
Mycobacterium. 
Following challenge, all the control animals and those 
which were immunized with antigen alone showed leukopenia 
accompanied with reduction of granulocytes and a 
corresponding increase in lymphocyte and monocyte counts. But 
the animals immunized with antigen in association with BCG or 
BCG only, showed higher TLC values, with a slight increase in 
the number of lymphocytes and monocyte counts. Many workers 
have shown that usual feature of kala-azar is a marked 
reduction in the number of all forms of granulocytes, leading 
to leukopenia with relative lymphocytosis (Aikat et al, 1979; 
Manson-Bahr 1971; Srivastava et al , 1983). In the present 
investigation, most of the control animals showed amastigotes 
in the peripheral blood smears, while the immunized animals 
did not show any parasite in the blood. Parasitaemia with L. 
donovani is reported to be a common feature in visceral 
leishmaniasis. Chulay et al (1985) have shown that L. 
donovani parasitaemia is common in patients with visceral 
leishmaniasis in Kenya. The level of parasitaemia was found 
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to be correlated with the density of parasites in spleen 
aspirate smears. 
The parasite burden from different organs of challenged 
animals revealed that animals immunized with leishmania 
antigen in association with BCG had significantly lower 
levels of spleen and liver parasitization compared to 
animals which were immunized with antigen alone, or control 
animals. However the animals which received soluble antigen 
in association with BCG had fewer liver and spleen parasites 
than other animals. These results were very much similar to 
that of Cook and Holbrook, 1983; who have performed 
immunization against L. donovani in experimental animals 
using glucan as an adjuvant. 
Other workers also reported the development of footpad 
lesions in hamsters following L. donovani infection (Jalees 
et al , 1981). The appearance of such post kala-azar dermal 
lesions is common in India (Heyneman 1971). They are known to 
be caused by identical serotypes of L. donovani (Bray et al , 
1973). The reticuloendothelial hyperplasia that follows 
infection with L. donovani affects the spleen, liver, mucosa 
of the small intestine, bone marrow, lymph nodes and other 
lymphoid tissues. Many of these cells are heavily 
parasitized. Lymphocyte infiltration is scanty. In the spleen 
and other lymphoid organs, there may be atrophy of 
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paracortical areas (white pulp), but plasma cells are 
numerous. The life span of leukocytes and erythrocytes is 
reduced, causing granulocytopenia and anaemia.Liver function 
is normal, and few hepatocytes are invaded, later, 
prothrombin production decreases. Together with 
thrombocytopenia, the prothrombin depletion may result in 
severe mucosal haemorrhages. Hypoalbuminaemia is associated 
with Oedema and other features of malnutrition. Diarrhoea may 
occur as a result of intestinal parasitization and ulceration 
of secondary enteritis. In the advanced stage, intercurrent 
infections are frequent, especially pneumonia, dysentery and 
tuberculosis and these are common causes of death (Report of 
WHO Expert Committee 1990). 
In our study hamsters which are immunized with parasite 
antigen only were also seen to develop granulomatous foci, 
hyperplasia of kupffer cells and atropy of hepatocytes. The 
liver architecture was distored. These tissue reactions were 
less obvious in antigen-BCG immunized groups, in which the 
liver architecture was maintained and the LD bodies were 
rarely seen in macrophages after 60 days of challenge. The 
splenic tissue of control animals showed accumulation of 
parasitized macrophages in red pulp, with an accompanying 
hyperplasia of the white pulp. After 60 days of infection, 
the white pulp was invaded by parasitized macrophages, in 
addition to many foci of tissue necrosis. Similar changes 
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were observed in animals which were immunized with antigen 
only, although they did not show tissue necrosis. In the 
antigen-BCG group such tissue reactions were minimal compared 
to other immunized groups. The fibrous reaction was obvious 
and the LD bodies were rarely seen in proliferated 
macrophages. 
BCG is a well known immunotherapeutic agent in human as 
well as in animal tumour systems. A non-specific BCG induced 
regression has been documented in several tumour types 
(Lemond 1973). BCG as an adjuvant has also been used in 
several vaccination studies against leishmaniasis (Costa et 
al , 1988) in mice model system. A one hundred percent 
protection against challenge (1 x 10 amastigotes) by 
purified L. mexicana amazonensis amastigotes was observed in 
mice immunized with microsomal preparation (POl-F) of L. m. 
amazonensis with BCG. Convit et al (1987) have carried out 
immunotherapy versus chemotherapy experiments in localized 
cutaneous leishmaniasis. The study revealed a similar cure 
rate (94X) when a combination of vaccine consisting of live 
BCG together with killed leishmania promastigotes was used to 
compare the results with a standard antimonial drug 
(meglumine antimonate). gene for control of this response is 
a human homologue to the murine resistance gene (Lsh/Bcg/Ity) 
which regulates macrophage priming/activation and acessory 
cell function, resulting in the rapid genertion of a cell-
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mediated immune response t o le i shman ias , mycobacter ia , and 
sa lmonel las ( B l a c k w e l l , 1989). 
F i n a l l y , the r e s u l t s o f t h i s s t u d y i n d i c a t e t h a t 
v a c c i n a t i o n o f go lden hamsters w i t h s o l u b l e l e i s h m a n i a 
an t igen in assoc ia t i on w i t h BCG was adequate enough t o e l i c i t 
c o n s i d e r a b l e immune p r o t e c t i o n (95%) a g a i n s t L. donovani 
c h a l l e n g e (1x10 p r o m a s t i g o t e s ) . T h i s p r o t e c t i o n was 
conf i rmed by est imated lower p a r a s i t e burdens i n l i v e r and 
sp leen compared t o c o n t r o l a n i m a l s . I n a d d i t i o n , t h e s e 
animals showed o ther parameters of immunity such as p o s i t i v e 
s k i n t e s t responsiveness a f t e r cha l l enge , increased an t ibody 
t i t r e s and high IgG and IgM l e v e l s , and h igh t o t a l leukocy te 
counts . Sco t t e t a l (1987) have a lso demonstrated t h a t BALB/c 
mice can be p ro tec ted aga ins t a f a t a l i n f e c t i o n (cha l lenged 
w i t h 1 X 1 0 " ) s t a t i o n a r y g r o w t h phase o f L.major 
promast igo tes) by i . p . immunizat ion w i t h a so lub le le ishmania 
a n t i g e n p r e p a r a t i o n i n c o n j u n c t i o n w i t h t h e a d j u v a n t , 
Corynebacterium parvum. The s o l u b l e le ishmania an t i gen was 
f u r t h e r separa ted i n t o n ine d i s t i n c t f r a c t i o n s by a n i o n 
exchange l i q u i d ch romatography , and t h e f r a c t i o n s were 
a n a l y z e d f o r t h e i r a b i l i t y : t o s t i m u l a t e T - c e l l s f r o m 
immunised m ice , t o be ab le t o r e c o g n i z e v a c c i n e - i n d u c e d 
an t i bod ies and, t o induce p r o t e c t i v e immunity. Only f r a c t i o n 
9 s t i m u l a t e d s i g n i f i c a n t immunity (76% p r o t e c t i o n ) . 
CONCLUSION 
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CONCLUSION 
S i n c e no i m m u n i z a t i o n t r i a l i s c o m p l e t e l y s u c c e s s f u l 
a g a i n s t L e i s h m a n i a s i s t h e r e f o r e a p r e l i m i n a r y t r i a l was made 
i n ou r s t u d i e s t o i d e n t i f y a c a n d i d a t e v a c c i n e . I n o r d e r t o 
a c h i e v e t h e goa l ] . . donovan i were c u l t u r e d i n v i t r o , u s i n g 
B r a i n H e a r t I n f u s i o n Agar medium i n w h i c h a s a t i s f a c t o r y 
g r o w t h was o b t a i n e d . D i f f e r e n t f r a c t i o n s o f L e i s h m a n i a 
a n t i g e n p r e p a r e d f r o m t h e s e c u l t u r e s w e r e f o u n d t o be 
i m m u n o l o g i c a l l y a c t i v e a g a i n s t p o s i t i v e k a l a - a z a r serum. 
P r e v i o u s s t u d i e s i n o u r l a b o r a t o r y i n d i c a t e d t h a t 
L e i s h m a n i a a n t i g e n a l o n e was u n a b l e t o e l i c i t s u f f i c i e n t 
p r o t e c t i o n , t h e r e f o r e , a s t r o n g a d j u v a n t , BOG, was used i n 
a s s o c i a t i o n w i t h L e i s h m a n i a a n t i g e n t o b o o s t up t h e 
i m m u n o l o g i c a l sys tem o f e x p e r i m e n t a l a n i m a l s . A c o n s i d e r a b l y 
h i g h e r p r o t e c t i o n a f t e r c h a l l e n g e w i t h l i v e L. d o n o v a n i 
p r o m a s t i g o t e s was o b t a i n e d i n a n i m a l s immunized w i t h s o l u b l e 
a n t i g e n i n a s s o c i a t i o n w i t h BOG, c o m p a r e d t o a n i m a l s 
immunized w i t h p a r t i c u l a t e and who le a n t i g e n i n a s s o c i a t i o n 
w i t h BOG. The e x t e n t o f i m m u n i z a t i o n , o r p r o t e c t i o n , was 
d e t e c t e d by a s s a y i n g t h e a n t i 1 e i s h m a n i a 1 a n t i b o d i e s , 
i m m u n o g l o b u l i n s l e v e l s and DTH r e s p o n s i v e n e s s t o l e i s h m a n i a 
a n t i g e n s . A n i m a l s i m m u n i z e d w i t h s o l u b l e a n t i g e n i n 
a s s o c i a t i o n w i t h BOG a lways showed h i g h e r a n t i b o d y t i t r e s 
compared t o a n i m a l s immun ized w i t h p a r t i c u l a t e and w h o l e 
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antigen in association with BCQ. Also, the level of IQG was 
found to be higher compared to IgM in hyperimmune sera 
samples. However, all the animals immunized either with 
antigen only or in association with BCG showed negative DTH 
responsiveness to Leishmania antigens. 
Percent protection in immunized animals was dectected 
by intraperitoneally injecting the experimental animals with 
1 X 10 promastigotes. Again the antibody titres were higher 
in animals immunized with soluble antigen in association with 
BCG compared to animals immunized with particulate and whole 
antigen in association with BCG. Also the level of IgG was 
always higher compared to IgM in hyperimmune sera. All the 
animals immunized with Leishmania antigen in association with 
BCG were found to be positive for DTH responsiveness after 
challenge. The macrophage migration inhibition was also 
higher in animals immunized with soluble antigen in 
association with BCG compared to animals immunized with 
particulate and whole antigen in association with BCG after 
challenge. Furthermore, minimum decrease in acid phosphatase 
activity was observed in animals immunized with soluble 
antigen in association with BCG compared to animals immunized 
with particulate and whole antigen in association with BCG 
after challenge. 
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In our haematological studies we found that TLC was 
higher in animals immunized with Leishmania antigen in 
association with BCG. The animals immunized either with BCQ 
alone or with Leishmania antigen in association with BCG 
showed higher TLC with slight increase in lymphocytes and 
monocytes compared to animals immunized with Leishmania 
antigen only. Furthermore, in organ parasite count studies, 
a significant reduction in splenic and liver parasite 
amastigotes was observed in animals immunized with Leishmania 
antigen in association with BCG, especially the animals 
immunized with soluble antigen in association with BCG after 
challenge. Histopathology of liver and spleen from antigen 
immunized group showed moderate number of L.D. bodies in the 
hyperplased macrophages compared to animals immunized with 
Leishmania antigen in association with BCG, The liver and 
spleen architecture in antigen-BCG immunized groups showed 
almost no changes or alterations. Some fibrous reactions were 
observed in spleen, but L.D. bodies were very rarely seen in 
hyperplased macrophages. 
On the basis of our results it was concluded that 
significant protection against JL. donovani infection can be 
achieved by intraperitoneal immunization of golden hamsters, 
in association with BCG. Furhtermore best results were 
observed in animals immunized with soluble Leishmania antigen 
in association with BCG. 
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